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ABSTRACT
The mechanism underlying the anticonvulsant and cerebroprotective 
activity of U-50488H was evaluated using ^ C a ++ uptake in rat Ficoll 
purified synaptosomes, (^H)-2 -deoxyglucose uptake in selected mouse
brain regions, (%)kainic acid binding to mouse forebrain synaptic
membranes and incidence of KA-induced lesions in the CA3 region of the 
mouse hippocampus.
U-50488H causes reduction in K+-evoked uptake. These effects
are comparable to those of the calcium channel blockers verapamil and 
nifedipine and seem to be related to calcium dependent mechanisms. 
Changes in saturability, specificity and dissociation constant values 
of kainic acid receptor binding were demonstrated in the presence of 
U-50488H at concentrations similar to those used in ^ C a ++ Uptake 
studies and in the presence of calcium and chloride ions.
The ability of U-50488H to block kainic acid binding was more 
pronounced on total specific binding than on high affinity binding.
The effects of U-50488H on neuronal metabolism in areas associated
with generation of seizures was evaluated. The kappa opiate
anticonvulsant did not have pronounced inhibitory effects on cerebral 
metabolism and it did not block the activation of metabolism induced 
by the stimulation of kainic acid receptors.
Significant differences were observed in the mean area of 
vacuolization induced by kainic acid in the CA3 area of the mouse 
hippocampus when comparing the U-50488H treated versus the neurotoxin 
treated group when assessed with parametric and non-parametric 
methods.
xiv
The absence of kainic acid-induced vacuolization in the CA3 region 
of the hippocampus in the presence of U-50488H, and the requirement of 
calcium and choride ions for U-50488H-increased affinity of KA at 
excitatory receptors and decreased Bmax suggest that U-50488H 
interfered with a sequence of events induced by excitatory amino acids 
during the course of the neurodegenerative effects induced by 
seizures.
U-50488H may be of potential value in the elucidation of the 
mechanisms underlying neuronal cell death after intense
depolarization.
xv
INTRODUCTION
Epilepsy is a symptom of central nervous system dysfunction, not a 
specific disease (Theodore, 1985).
The epilepsies are a family of neurological disorders that have in 
common a transient, recurrent, self-sustained interruption of normal 
brain functions and a simultaneous hypersynchronous activation of a 
large population of neurons in one focal area or generally throughout 
the brain (Ditcher & Ayala, 1987). Patients with epilepsy often have 
frequent intertictal discharges seen as spikes or sharp waves on the 
EEG. The seizures are nearly always correlated with abnormal and 
excessive EEG discharges. Clinical and EEG observations suggest that 
seizure activity in most patients with epilepsy has a focal or at least 
a relatively localized origin (Rail & Schleifer, 1980).
In summary, epilepsy refers to many types of recurrent seizure 
disorders produced by excessive paroxysmal neuronal discharges. It is 
increasingly apparent that there are many conditions that cause 
epilepsy and that the possible causes of seizures are numerous.
It was early proposed (Jackson, 1890) and later confirmed in 
microphysiological' studies (Jasper, 1969) that the capacity of some 
populations of neurons to generate high-frequency synchronous 
discharges underlies focal cortical epileptogenesis. From these early 
studies it was postulated that epilepsy existed in two broad forms: 
focal or partial epilepsy due to a discrete cortical abnormality and 
generalized or centreencephalic epilepsy due to an abnormality in deep 
subcortical grey matter (Ditcher & Ayala, 1987). As clinical and
1
electroencephalographic analysis have drastically Improved differential 
diagnosis, a better recognition of the true epileptic seizures has 
resulted (Theodore, 1985).
Today, the epilepsies are described in terms of their 
manifestations on close-circuit- television videotape and 
electroencephalography, their mode of transmission, their age of 
penetrance, their age distribution, and their response to antiepileptic 
drugs (Delgado-Escueta, et al,. , 1983).
A great variety of hypotheses have been proposed and discussed to 
explain epileptic activity. The search for a unified theory about the 
cellular mechanism of epilepsy has been sought with the hope of 
developing pharmacological means that could be used to suppress the 
abnormal activity. So far, no single theory provides the common element 
to explain the epileptic condition.
Epileptic seizures are caused by an abnormal discharge of cerebral 
neurones which result in some measurable behavioral alteration or 
subjective sensation in the patient. The causes of epilepsy remain 
elusive, and may be detected in some patients but not in others. 
Epilepsy is nevertheless a "symptom complex", which in some patients 
may be a genetic abnormality (Porter, 1986).
Irrespective of their diversity of origin, seizures are similar in 
one aspect: during a seizure neurons in the brain fire together in
unusual synchrony. The reason why neurons spontaneously begin to fire 
in abnornal synchrony is not known. A patient with epilepsy has 
recurrent spontaneous seizures, not just one. Seizures vary widely in 
duration, intensity, behavioral manifestations, cerebral spreading and 
sensitivity to drugs. Even between seizures there is often abnormal
electric activity in the brain of the epileptic patient. Current 
hypotheses include the roles of excitatory and inhibitory synaptic 
activity, ionic mechanisms that may be independent of synaptic 
communication between nerve cells, and specific brain structures or 
circuits (Barnes, 1987). In the case of synaptic activity, it has been 
hypothesized that specifically timed inhibitory neuronal activity and 
excitatory activity is required for synchronous firing and the 
initiation of a seizure (Engel, 1987). Engel proposes that the firing 
of a small group of excitatory neurons may shut down a larger region of 
brain activity by stimulating inhibitory neurons that have synaptic 
connections throughout that region. A secondary excitatory pulse, 
properly timed, could then produce a synchronous discharge because all 
of the neurons begin firing at once. Thus, there is increased synchrony 
within the primary epileptic zone, which then serves to recruit 
adjacent and distant areas of the brain. According to Prince (1978), it 
is the suppression of inhibitory events, not their dominance, that 
leads to seizures. Drugs that enhance GABA-mediated inhibition are 
anticonvulsants (diazepam) and drugs that block inhibition are 
convulsants. Cell synchrony has been explained in terms of a change in 
concentration of certain ions in the space surrounding brain neurons. 
This change, coupled with or perhaps due to a shrinkage of 
extracellular space, may induce the transition to seizure. This 
mechanism would be independent of synaptic transmission among neurons. 
A drop in calcium levels may increase neuronal excitability by 
decreasing synaptically mediated inhibition and also by decreasing the 
inhibitory influence of potassium efflux that is calcium-dependent 
(Yaari, 1987).
Research in the last 30 years has been concentrated on models of 
cortical focal epilepsy. Two paradigms that emphasize how cell 
communication is abnormal in epilepsy are the mirror or secondary 
focus of Morrel (1979), and the kindling phenomenon of Goddard (1983). 
The physiological investigations in the context of these two paradigms 
have revealed long-lasting alterations and enhancement of evoked 
potentials and suggests that long-term potentiation may involve the 
same process as kindling. A more recent model of epilepsy is the 
generation of seizure-like discharges in slices of brain tissue 
(hippocampus) maintained in vitro. All experimental models of epilepsy 
are limited in many respects and may resemble only certain aspects of 
the human disorder. Nevertheless, these experimental models may provide 
the key to understanding how seizures are initiated and the underlying 
basic mechanisms during a discharge and between seizures.
A recent revival of the studies of generation, propagation, and 
control of generalized seizures has shown that subcortical structures 
are of great importance in the development and propagation of epileptic 
activity. There seems to be at least one initiation site for seizures 
in the rat brain, the area tempestus (Miller & Ferrendelli, in press). 
and at least two policing structures capable of preventing seizures 
from occurring: the substantia nigra and the anterior thalamus (Gale, 
1985). Whether these brain regions are important in the regulation of 
seizure activity in humans is not yet known. Questions about the 
cellular events that underlie the control mechanisms for seizure 
propagation in both local and generalized seizures remain to be 
answered. The role of GABAhas been emphasized as the most important 
inhibitory neurotransmitter, of NMDA receptors for excitatory functions
and of norepinephrine and the opioid peptides as modulatory substances, 
but little is known about how these transmitters express their role on 
the target structures, or which target structures create the 
generalized seizures (Ditcher & Ayala, 1987).
Partial (focal) epilepsies are characterized by seizures in which 
the first clinical and electroencephalographic changes indicate 
activation of an anatomic or functional system limited to a part of one 
or both hemispheres (Delgado-Escueta, e£ al. , 1982). The location of 
the seizure focus determines the clinical presentation of the seizure. 
Partial epilepsies are the most common form of seizure disorder, 
occurring in about 67 per cent of all adult patients with epilepsy and 
in about 40 per cent of all children with epilepsy (Delgado-Escueta, et 
al., 1982).
Partial seizures in children and young adults are often due to 
atrophic nonprogressive structural changes resulting from trauma or 
birth injuries (foci). The focus is the area of maximal spontaneous 
epileptiform abnormality when activated with methohexital. Biochemical 
abnormalities in foci removed at neurosurgery have given contradictory 
results. Van Gelder, et al.. (1972) found that contents of taurine and 
glutamic acid were reduced and that glycine content was elevated in 
these foci, whereas contents of aspartic acid and of GABA were 
diffusely low in cerebral cortex of epileptic patients. Data suggesting 
that an elevated content of glutamic acid may be involved in the 
increased neuronal firing in some epileptigenic foci has been provided 
by Perry & Hansen, (1981). Glycine content was markedly elevated in 
some foci.
The EEG hallmarks of focal epilepsy both in animal models and in 
human epilepsy are the ictal, or seizure, discharge and the interictal 
spike discharge (ID).
The mechanisms by which cellular events lead to the intertictal 
spike are important to our understanding of the pathogenesis and 
treatment of clinical focal epilepsy. The interictal spike is a 
prominent extracellular field potential that is associated with 
large-amplitude, prolonged depolarization shifts in neuronal membrane 
potential and with bursts of action potentials.
The neuron engaged in seizure activity has an abnormal feature 
known as "paroxysmal depolarizing shift" (PDS), and is often 
associated with high-frequency bursts of action potentials, and 
synchronous discharge of other cells of the same cortical columnar 
group. The PDS is a sudden depolarization of the membrane potential, 
which lasts hundreds of milliseconds and usually triggers a series of 
action potentials on its rising phase. The PDS, as recorded in a 
single cell, is coincident with the activity of a large group of cells. 
The synchronous activity of the group is reflected by the 
extracellularly recorded field potential. The PDS is followed by a 
hyperpolarizing potential (the post-DS HP) and neuronal inhibition 
(Johnston & Brown, 1984; Ditcher and Ayala, 1987).
The interaction of factors such as 1) the existence of intrinsic 
neuron membrane properties that lead to pacemaker activity in specific 
subsets of neurons; 2) reduction of inhibitory control mechanisms and 
3) excitatory synaptic coupling among neurons of the epileptogenic 
region allow some predictions about the alterations that might give 
rise to epileptogenesis in humans.
IC is well established that direct block of gamma-aminobutyric acid 
(GABA), a major inhibitory neurotransmitter, causes seizures, and that 
augmentation of GABA function can protect against seizure activity. 
There is considerable circumstantial evidence that supports the GABA 
hypothesis of seizure disorders. In particular, modulatory receptor 
sites on the GABA receptor-ionophore complex of the post-synaptic 
membrane have been described for drugs with anticonvulsant activity, 
including benzodiazepines and barbiturates. It would appear likely
i
that an impairment of GABA-mediated inhibitory transmission or 
increased glutamate could contribute to the genesis of at least some 
kinds of seizure disorders (Olsen, 1982).
When incoordination between the GABA system and other 
neurotransmitter and modulator systems is present, the defect might 
involve a local brain region, several brain regions, or the entire 
CNS. A critically placed local incoordination might have drastic 
reverberations in the whole nervous system, as in the case of 
generalized seizures arising from focal cortical lesions. With 
increasing excitatory input, there would be an increased tendency to 
release pacemaker neurons and abnormal behavior might be released. 
Major causes of seizures may be the loss of inhibitory GABAergic
I
terminals at the site of focal cortical, epilepsy or a disturbance in 
various other aspects of GABAergic function or excitatory amino acid 
transmission (Roberts, 1976).
Glial cells can serve as one major restraining influence on the 
spontaneous activity of neurons by decreasing the intrinsic excitatory 
levels of neuronal membranes below their spontaneous firing levels. 
Such restraint could be exerted by removing substances from the
extraneuronal environment in the region of synapses (K+ or protons), by 
adding substances to it, or by the diffusion of substances from it or 
to it in such a way as to shunt the depolarizing ionic currents.
Because glial cells are important in the control of 
neuroexcitability, the gliosis resulting from injury may in turn be 
playing an important role in the generation and spread of partial 
epilepsy. Direct proof has been provided that K+ homeostasis in brain 
is at least partly due to an active transport system into glial cells 
(uptake). A second kind of transport is passive: redistribution by
spatial buffering currents. The electrochemical gradient across glial 
membranes is so close to the equilibrium state for K+ that this type 
of transport is possible. Spatial buffering currents are generated when 
the membrane potential differs from the K+-equilibrium potential by an 
unequal distribution of extracellular K+-concentration along the cell 
membrane. Local elevation of [K+]o results in considerable differences 
between the membrane potential and K+-equilibrium potential. 
Oligodendrocytes have a great capacity to buffer K+ by passive current 
movement (Kettenmann, 1986). K+ can then be released to the 
extracellular space from a glial process from the original source; this 
has been proposed as a "spatial buffering" (Kuffler & Nicholls, 1976; 
Orkland, 1969).
At the cellular level much of the communication that takes place 
between sensory transducer and neuron, between neuron and neuron, and 
between neuron and effector cell is believed to occur through the 
extracellular liberation of a substance or a combination of substances 
that interact with specialized regions of the membranes of neurons or
muscle and gland cells to produce either excitatory or inhibitory
effects.
Clectrotonic interactions through gap junctions as well as field 
effects are also of importance in neural information processing. 
Changes such as intracellular pH, levels of Ca‘t_+, and membrane 
potential may play a role in determining the extent, efficacy, and 
stability of gap junctions, and the number and type of neurons that are 
linked at any time.
In the case of an excitatory substance, its action is believed to
result in conformational changes In the membranes upon which it
impinges, increasing the permeability to cations such as Na+ (result of
the opening of Na+ channels), and in turn decreasing the potential 
across the membrane (depolarization). Synaptic excitatory effects upon 
a neuron occur most frequently on dendrites. An inwardly directed Na+ 
current usually is believed to be responsible for most of the observed 
depolarization of post-synaptic membranes. Increases of free 
intracellular Ca++ that may occur by inward flow or by release from 
mitochondria during nerve activity activate the opening of K+ channels 
and have other far reaching metabolic effects. The repolarization of 
the membrane is produced by the outward K+ currents, Na+ channel 
Inactivation, and the intervention of Ca++- and Mg++-dependent 
adenosine triphosphatase to restore the Ca++ balance. The Na+-K+ pump 
counteracts the voltage-dependent Na+ influx during excitation to 
reduce passive Ca-1-*- influx (Roberts, 1984). Thus, the Na+ and Ca-*-*" 
channels are important target sites for studying standard 
anticonvulsant drugs (Johnston & Ayala, 1975) and other new molecules.
A variety of natural toxins, chemicals, and therapeutic drugs have 
been found to modify the gating kinetics of the Na+ channels, thereby 
altering the excitation pattern (Narahashi, 1974). A pivotal role in 
the maintenance and restoration of ion gradients that are necessary for 
the regulation of neuronal excitability is played by Na+ and 
K+-dependent adenosine triphosphatase (Askari, 1982).
The control of intracellular Ca++ is not well understood. In 
addition to the (Na+ + K+)-ATPase, an ecto-Ca^-stiraulated ATPase of 
uncertain function (Trams & Lanter, 1978), and two Ca++ transport 
systems, the calmodulin-sensitive Ca^-ATPase and a reversible 
Na+-Ca++-exchange (Siegel, et al. , 1981) have been described. The
contribution of each of these systems is so far unknown. Recent work 
suggests that Na^-Ca'1-*'-exchange processes may act at the cell plasma 
membrane as well as at the mitochondrial outer membrane (Schellemberg 
& Swanson, 1983).
Defects in transport have been suggested in epilepsy and could 
involve reduced clearance of extracellular K+ released from depolarized 
neurons via passive mechanisms (spatial buffering) or active transport 
mediated by (Na+ + K+)-ATPase (Siegel, £t al. , 1981). Whether changes 
in ion pumps are the primary cause of epilepsy or a secondary effect 
resulting from epilepsy remains unclear. An understanding of the 
relationship between anticonvulsant molecules and the movements of 
Na+ , K+ , and Ca++ will provide some insight into the ionic mechanisms 
in epilepsy.
The involvement of excitatory amino acids in neurotransmission in 
the mammalian brain via multiple excitatory receptors is now supported
by electrophysiological, anatomical, and neurochemical evidence (Olney, 
1969, 1978; Watkins & Evans, 1981; Shariff, 1984).
Studies of the relationship between the structure of a series of 
glutamate analogues, their excitatory potency and their 
dendrosomatotoxic activity have led to the discovery of a number of 
experimentally useful "excitotoxins"; examples are analogues of plant 
origin, such as kainate, ibotenate, domoate, quisqualate, and the 
synthetic compound N-methyl-D-aspartate (NMDA) (Olney, 1978; Watkins & 
Evans, 1981). The neurotoxic properties of these compounds when 
injected locally are similar to those of glutamate: initial
depolarization followed by severe neuronal degeneration with relative 
sparing of axons of passage and glial cells, and with much more 
toxicity towards some neurons than others. This effect, which can lead 
to complete neuronal destruction, is believed to occur through the 
interaction of the "excitotoxin" with receptors for an endogenous 
excitatory transmitter, located on neuronal somas and dendrites, where 
the primary "excitotoxic" effects occur. It has been implied that the 
excessive depolarization produced by the excitatory substance is the 
cause of neuronal cell death (Watkins & Evans, 1981; Olney, et al. . 
1974; Ben-Ari, 1985).
Kainic acid (KA), 2-carboxy-4-(1-methylvinyl)-3-pirrolidineacetic 
acid which was isolated three decades ago from the seaweed Digenea 
simplex, has been used as an ascaricide In Japan (McGeer, 1978), 
(Figure 1).
Domoic and quisqualic acids, other analogues of glutamate, share 
the antihelmintic action and were identified as active principles of 
other biological extracts used for the same purpose (Olney, 1969). KA
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Figure 1. Chemical structure of kainic acid.
is the most potent of these analogues (Coyle, ej: al., 1984). Parenteral 
and intracerebral injections of KA produce "axon-sparing lesions", 
selectively destroying the neurons of a given brain region (Ben-Ari, 
1985).
Excitotoxic mechanisms may be responsible for the nerve cell loss 
in a wide range of neurological diseases including stroke, cerebral 
palsy, Alzeheimer's disease, Huntington's chorea, epilepsy and other 
chronic degenerative diseases. Excitatory amino acids may be important 
in the pathophysiology of seizure disorders. Seizure activity can be 
initiated by the systemic or focal intracerebral administration of 
excitatory amino acids. The pattern of KA brain damage and the regional 
distribution of this damage is reminiscent of that associated with 
human temporal lobe epilepsy (Schwarcz & Meldrum, 1985; Ben-Ari, 1985).
Intracerebral injections of KA and other excitatory amino acids 
produce recurrent epileptiform discharge, motor convulsions and damage 
at the site of injection and in structures distant from the injection 
site. The distal damage is characteristic of KA and seemingly 
associated with the limbic status epilepticus and paroxysmal discharges 
generated by this compound (Ben-Ari, et al, 1980; Ben-Ari, 1985).
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The kainate model of limbic temporal epilepsy has been extensively 
studied. It is particularly useful for the study of the evolution, 
propagation and pathological consequences of epileptic discharge in the 
limbic system (Ben-Ari, 1985). Other models of epilepsy have been used 
such as alumina cream (Gastaut, et al. , 1952), cobalt (Mutaris, 1967), 
zinc (Chung & Johnson, 1983), ouabain (Pealey, et al. , 1969), and
continuous electrical stimulation of the amygdala in the previously
kindled rat (McIntyre, ££ al., 1982). The powerful excitatory action 
of KA has been described in several brain areas (Watkins & Evans, 
1981). In vertebrate spinal cord, KA produces a large and often 
irreversible depolarization which is associated with a reduction in 
input resistance and depends on the presence of extracellular Na+ 
(Evans, 1980). It is possible that the activity of KA is due to an 
increase in Ca++ permeability. This would explain the strong 
conductance increase and the powerful depolarization, since Ca4-4" 
carries more current than Na+ and has a very positive reversal 
potential because of its low intracellular free concentration (Puil, 
1981).
The hippocampus has been the object of numerous studies examining 
the electrophysiological effects of KA. The effects are particularly 
more prominent in CA3 pyramidal cells than in CAl. This effect appears 
to be a synaptic depression, affecting the inhibitory post-synaptic 
potentials, and, with higher doses, the excitatory post-synaptic 
potentials. It has been suggested that the action of kainate is at
least partially due to a reduction of the GABAergic inhibitory drive.
In keeping with this hypothesis, the excitatory phenomena which occur 
following KA administration can be interpreted as being secondary to 
decreased inhibition (Evans, 1980).
It has been suggested that the damage inflicted upon the brain by 
kainic acid has a two-fold etiology: 1 ) a "local" direct toxic effect
at the site of the injection, and 2 ) a "distant" pathological damage
which is related to the epileptogenic effects of the drug. There are 
major differences between the characteristics of local and distant 
damage. The former is associated with massive early microglial
proliferation, perhaps of vascular origin. In contrast, glial 
proliferation in the hippocampus after injection of kainate into the 
amygdala is not manifested until 4-6 days after the injection, i.e. 
subsequent to the onset of neuronal damage (Ben-Ari, et al, 1980). It 
has been postulated that the depolarization produced by excitotoxins 
will cause "energy-dependent homeostatic mechanisms to draw heavily on 
the cell's energy stores in an effort to restore ionic balance, with 
cell death ensuing when energy stores are exhausted or lethal 
alterations in the composition of the cell's internal milieu have 
occurred" (Olney, 1978). The administration of anticonvulsants at doses 
sufficient to prevent the development of paroxysmal discharges fails 
to prevent the local neurotoxicity of KA. In contrast, anesthesia with 
gamma-butyrolactone or chloralhydrate-pentobarbital protects 
hippocampal neurons, suggesting that the anesthetic action plays a role 
in the protection of these neurons (Ben-Ari, 1985) via interactions 
with the GABA receptor complex.
The mechanisms of "local" damage remain to be clarified. The local 
toxic action of kainate may be caused by a complex series of effects, 
rather than a single mechanism. A possible direct effect of KA on the 
vasculature of the injected locus remains to be investigated.
The "distant" damage produced In structures away from the injection 
site or in structures protected by the blood-brain barrier are of two 
types: The first is selective seizure-related damage, i.e., the damage 
to CA3 pyramidal neurons. The crucial role of the mossy fibers has been 
stressed: destruction of the mossy fibers provides immediate protection 
of the CA3 region against intracerebroventricular KA (Ben-Ari, et al. 
1980). Several features of the mossy fiber/pyramidal cell synapse might
cause the selective seizure-related damage of the CA3 pyramidal 
neurons. Large increases in intracellular Ca++ associated with the 
seizures could exceed the cell capacity to buffer the Ca++, thus 
leading to an increase in intracellular free Ca++ which by means of 
proteolysis or blockade of the Ca++ proton exchange across the 
mitochondrial membrane may cause neuronal damage (Schanne, et al. .
1979). Other factors exclusively localized to the mossy fibers may be 
released and produce damage during seizures: an endogenous kainate-like 
chemical (endokain), which will excite the CA3 pyramidal neurons by 
means of postsynaptic receptors involved in the control of Ca"*"1" 
channels; dynorphin, which is present in large amounts in the mossy 
fibers and could play a role in this event; an agent released with the 
transmitter during severe seizure discharge such as Zn"*”*" which is 
particularly concentrated in the mossy fibers and very efficiently 
blocks Na+-K+ ATPase and glutamate decarboxylase (Ben-Ari, 1985). The 
second type of damage is a non-selective seizure-related damage that 
can be blocked by administration of anticonvulsants, and is not
associated with a specific synaptic connection, best illustrated by a 
necrosis seen in the pyriform region. This type of necrosis is a lesion 
typical of anoxic-ischemic damage. It has been suggested that the
overactivity caused by KA in this region leads to release of water and 
metabolites and subsequent edema. Compressing drainage vessels against 
the skull in the fronto basal region results in a local disturbance of 
blood flow and anoxic-ischemic changes. This kind of damage is also
produced in other brain regions, such as the lateral septum and the CAl
field of the hippocampus (Ben-Ari, et al., 1980; Drejer, et al., 1985).
The kainate model of epilepsy is similar to human temporal lobe 
epilepsy and fulfills some of the criteria to constitute a useful test 
model for developing new anticonvulsant drug treatment. The kainate 
model can shed light on temporal lobe epilepsy in humans and provide a 
better understanding of the normal and pathological functioning of the 
hippocampus and other limbic regions.
The development of excitatory amino acid antagonists as
antiepileptic agents will provide compounds which can block chemically- 
induced seizures and the neurotoxicity of excitatory amino acids and 
related analogues.
U-50488H (trans-3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl) - 
cyclohexyl)-benzeneacetamide) (Figure 2) was discovered in the course 
of the search for an improved analgesic with minimal abuse
potential(Szmuszkoviccz & Von Voigtlander, 1982). This compound
interacts exclusively with the kappa opioid receptor (Lahti & Von
Voigtlander, 1982).
U-50488H is an effective anticonvulsant against 
electroshock-induced seizures in the rat (Tortella, et al., 1984; 1986; 
Von Voigtlander, et al., 1986), and produces a dose- and time-dependent 
suppression of the fully kindled amygdaloid seizure in the rat 
(Tortella, personal communication). Naloxone at high doses partially 
antagonizes this anticonvulsant activity, which has a rapid onset and 
relatively long duration of action.
The effect of U-50488H against electroshock-induced seizures 
suggests potential efficacy against epilepsies of the generalized or 
partial types. It has shown an anticonvulsant profile comparable to
U-50488H
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Figure 2. Chemical structure of U-50488H.
that seen with diphenylhydantoin (phenytoin) (Tortella, e£ £l., 1986).
U-50488H blocks the convulsions induced by KA, administered either 
intravenously or directly into the lateral ventricle in mice, and by 
the Ca++ channel agonist, Bay K 8644. Standard anticonvulsants 
(phenytoin and phenobarbital) and the calcium antagonist verapamil were 
ineffective in blocking kainic acid-induced convulsions (Von 
Voigtlander, ££ fll. , 1986). U-50488H at large doses antagonizes the
lethal effects of KA and the convulsant and lethal effects of NMDA. 
This activity may be related to a more general cerebroprotective 
effect of this compound (Tang, 1985); it is partially antagonized by 
narcotic antagonists. This suggests that the stimulation of kappa 
receptors by U-50488H results in protection against seizures and may 
indicate the possibility that an endogenous ligand for the kappa 
opioid system is involved in the regulation of neuronal excitability.
I hypothesize that the mechanism of anticonvulsant activity 
observed with U-50488H is related to the involvement of excitatory 
amino acid neurotransmitters and Ca++ mediated events at the kappa 
opioid receptor and that the generalized cerebroprotective effect of 
this compound may be secondary to the anticonvulsant activity.
To test my hypothesis I specifically propose to approach:
I
i) The biochemical interaction of U-50488H with Ca++ in a rat brain 
synaptosomal preparation and determine the -^’Ca++ uptake at rest and 
under depolarizing conditions in the presence or absence of this 
compound.
ii) The excitatory amino acid (EAA) contribution to this anticonvulsant 
activity by studying the kinetic parameters of a (%) -kainic acid 
(^H)KA) binding assay, Braax and K<j, with mouse neuronal membranes.
ili) The metabolic changes by determination of <^H)-2-deoxy-glucose 
uptake (Von Voigtlander, s£ si- .  1983, Sokoloff, s£ si., 1977) under 
KA-induced activation in several cortico-limbic areas of the mouse 
brain.
iv) Finally, to correlate the biochemical and metabolic findings with 
the morphological changes observed in the mouse hippocampus after KA, 
the anatomical lesions produced by intracerebroventricular (i.c.v.) 
injections of KA, and the protective effects of U-50488H on the 
induction of these lesions quantitated by image analysis.
METHODS
I. 45Ca++ UPTAKE TECHNIQUES
A. LABELED CALCIUM
1. RADIOLABELED CALCIUM - The ^-calcium chloride [a] in aqueous 
solution used in all preparations was purchased from Amersham 
International PLC [a]. The labeled calcium used was from one of several 
lots having a specific activity of 10-40 millicuries per milligram of 
calcium at a concentration of 1-5 millicuries/ml of calcium chloride 
solution.
2. UNLABELED CALCIUM - Calcium chloride dihydrate was purchased from 
Mallinckrodt, Inc. [b],
B. RAT FOREBRAIN SYNAPTOSOMES.
1. TISSUE COLLECTION AND PREPARATION - Male rats (150-250g) from
Charles River Breeding Laboratories [c] were decapitated and the brains 
quickly removed. Synaptosomes were prepared as follows: dissected
forebrain or whole brain was homogenized in ice cold sucrose solution 
(0.32 M) also containing sodium Hepes (0.5 mM; pH 7.4) (Appendix 1A)
(Fleming, et al, 1980). Approximately 1 g of brain tissue was
homogenized with 60 ml of the sucrose buffer with a glass-teflon 
homogenizer (0.15 mm clearance) [d] at 900 RPM (12 strokes), with the
tissue maintained in an ice bath (4 C) at all times. The tissue
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homogenate was diluted and centrifuged [e] at 3,000 RPM (l,000g) three 
times for 1 0 minutes in polycarbonate bottles and the supernatant 
retained. The pooled supernatants were centrifuged at 20,000 RPH 
(49,600g) for 10 minutes and the supernatant discarded. The pellet was 
resuspended to obtain a crude synaptosome preparation which was layered 
on a Ficoll density gradient [f] made up of 4 ml Ficoll 10%, and 6 ml 
Ficoll 4% in 0.32 M sucrose (Appendix IB). Four milliliters of the 
crude preparaticn were layered on each tube. The gradients were 
centrifuged [g] at 13,000 RPM (20,700g) for 40 minutes in a swinging 
bucket rotor [h].
The cellular material at the interface was collected and pooled. 
The synaptosomes were centrifuged at 20,000 RPM (49,600g) for 10 
minutes. The supernatant was discarded and the pellets resuspended in a
5.6 mM KC1 incubation medium (Appendix C), homogenized at 900 RPM (8 
strokes) and centrifuged at 20,000 RPM (49,600g) for 10 minutes. The 
supernatant was discarded and the washing repeated twice. Synaptosomes 
were equilibrated with incubation medium lacking CaCl2 but containing
5.6 mM KC1 (Appendix 1A), at a final protein concentration of 1.5-2.0 
mg/ml.
2. PROTEIN DETERMINATION - The protein content of the synaptosome 
preparation was determined by the Bio-Rad Protein Micro Assay [i], 
(Bradford, 1976). Dye reagent concentrate (0.2 ml) was added to 0.8 ml 
of the diluted synaptosomal preparation, then mixed and incubated for 
45 minutes at room temperature. Absorbance was read at 595 nm on a 
spectrophotometer [ j ] and protein concentration was determined from a
standard curve using bovine serum albumin (range of 1 - 2 0 ug) as a 
standard.
3. MORPHOLOGICAL EVALUATION OF SYNAPTOSOMES BY ELECTRON MICROSCOPY - 
The integrity of synaptosomes was determined morphologically by 
electron microscopy after isolation. Synaptosomes were fixed by 
diluting with an equal volume of 6% glutaraldehyde in 0.2 M phosphate 
buffer (to a final concentration of 3% gluraraldehyde, 0.1 M phosphate 
buffer, pH 7.0), and allowed to fix for 1 hour at room temperature. 
Following three 10 minute rinses in buffer (0.1 M phosphate, pH 7.0), 
samples were further fixed in 1 % osmium tetroxide for 1 hour, then 
rinsed with three 10 minute buffer changes. Samples were dehydrated 
with graded ethanols through 1 0 0%, rinsed with propylene oxide, and 
embedded in Polybed 812 [o]. Thin sections (60-80 nm) were cut with a 
diamond knife on a Dupont-Sorvall MT 5000 ultramicrotome [y], stained 
with uranyl acetate and Reynolds lead citrate (Reynolds, 1963), viewed 
and photographed with a Phillips 201 electron microscope [m].
C. 4 5 Ca++ UPTAKE STUDIES
Synaptosomes were preincubated at 37 C for 10 minutes in 
calcium-free medium, drug solutions were added, and 1 or 1 0 minutes 
later the synaptosomes were loaded with ^^Ca++ for 8 sec. The uptake 
was initiated by rapidly mixing 0.1 ml of incubation medium (Appendix 
2C) supplemented with ^^Ca++ at a specific activity of 0.1 mCi/mMol/L. 
Uptake was stopped by diluting the samples with 3.0 ml of ice cold 
incubation medium without added calcium but supplemented with 0.5 mM 
LaClj. Extracellularly bound calcium was then displaced by incubation
at 0 C for 20 minutes in the incubation medium containing lanthanum 
(Gripenberg, gt al., 1980).
Synaptosomes were collected by vacuum*filtration on Whatman GF/A 
filters [k] 3.7 cm in diameter. The synaptosomes retained on the
filters were washed with 5 ml (4x) fresh ice cold lanthanum medium 
(Appendix 1C & 3C) to eliminate the unbound radioactive calcium.
After drying by suction, the filters were placed in counting vials 
containing 15 ml of ACS scintillation medium [1]. Radioactivity trapped 
on the filters was measured by liquid scintillation spectroscopy at a 
counting efficiency of 34%, after the samples solubilized in 15 ml of 
ACS were kept in the dark overnight to minimize chemoluminescence.
The non-specific binding to filters was determined using incubation 
medium instead of synaptosome suspension. Control values were 
determined with 5.6 mM KC1 incubation medium (Appendix 1C).
Synaptosomes were depolarized by adding 74.4 mM KC1 to the -^’Ca'*-+ 
solution for a final 40 mM KC1 concentration. The filter discs were 
treated for at least 2 hours in incubation medium supplemented with 
2.2 mM CaCl2 - This treatment decreased the non-specific binding of 
-^>Ca++. The incubation medium was prepared daily as were the solutions 
of C^a"*-*" an<i drugs. In order to retain isoosmolarity of the medium, 
the concentration of sodium was decreased when that of K+ was 
increased.
Effects of incubation time, K+ and proveratrine [ac] 
depolarization, and Na+ ion absence on ^^Ca++ uptake were determined. 
In addition the effects of Ca++ channel agonists and antagonists, U- 
50488H, morphine, naloxone, and excitatory amino acids were examined.
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II KAINIC ACID BINDING ASSAY TECHNIQUES
A. LIGAND
1. RADIOLABELED LIGAND - The radiolabeled KA [r] used in all binding 
studies was purchased from Amersham International PLC.
The radioligand had a specific activity of 5.0 millicuries per 
millimole at a concentration of 1 . 0 microcuries/microliter of a 2% 
ethanol aqueous solution.
2. UNLABELED LIGAND - Kainic Acid was purchased from Sigma Chemical 
Company [s].
B. SYNAPTIC MEMBRANE PREPARATION
1. TISSUE PREPARATION - Charles River CF-1 male mice were decapitated 
and the brains rapidly removed for preparation of the crude synaptic 
membrane fraction as described by London & Coyle (1979). This procedure 
is stated as follows: the tissue was homogenized in 2 0 0 ml of
glass-distilled water (GDW) at 700 RPM in a Potter-Elvehjem glass
i
homogenizer fitted with a Teflon pestle [d]. The homogenate was 
dispersed with a Brinkman homogenizer [aa] at setting 6 for 30 seconds. 
Tissue suspensions were centrifuged [e] at 16,000 RPM (30,590g) for 10 
minutes. The membrane pellets were resuspended, recentrifuged, and 
washed sequentially in 100 ml of Tris buffer (Appendix 2A). The 
suspension in buffer was incubated for 30 minutes at 37 C to dissociate 
any glutamate bound to the membranes. After centrifugation for 10
minutes at 16,000 RPM, the pellet was suspended In Tris buffer at 4 C 
to a concentration of 0 .1 -0 . 6 mg protein/ml and used the same day for 
the binding assay.
2. PROTEIN DETERMINATION - The protein content of the membrane 
preparation was determined by the Bio-Rad Protein Micro Assay 
(Bradford, 1976). To 0.8 ml of the diluted membrane preparation 0.2 ml 
of the dye reagent concentrate [i] was added, mixed and incubated for 
45 minutes at room temperature. Absorbance was read at 595 run on a 
spectrophotometer [j] and the protein concentration was determined from 
a standard curve using bovine serum albumin (6 concentrations) within a 
range of 1 - 2 0 micrograms as a standard.
3. MORPHOLOGICAL CONTROL OF SYNAPTIC MEMBRANES BY ELECTRON 
MICROSCOPY - The homogeneity of synaptic membranes was determined 
morphologically by electron microscopy after preparation. Synaptic 
membranes were fixed by diluting with an equal volume of 6% 
glutaraldehyde in 0.2 M phosphate buffer (to a final concentration of 
3% gluraraldehyde, 0.1 M phosphate buffer, pH 7.0), and allowed to fix 
for 1 hr at room temperature. Following three 10 min rinses in buffer 
(0.1 M phosphate, pH 7.0), samples were further fixed in 1% osmium 
tetroxide for 1 hr, then rinsed with three 1 0 min buffer changes. 
Samples were dehydrated with graded ethanols through 100%, rinsed with 
propylene oxide, and embedded in Polybed 812 [o]. Thin sections (60-80 
nm) were cut with diamond knives on a Dupont-Sorvall MT 5000 
ultramicrotome [n] , stained with uranyl acetate and Reynolds lead
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citrate (Reynolds, 1963), viewed and photographed with a Phillips 201 
electron microscope [m].
C. (3H)KAINIC ACID BINDING ASSAY
1. BINDING ASSAY TECHNIQUE- Aliquots of the crude synaptic membranes
were incubated in triplicate at 4 C for 60 minutes in a 2 ml total
volume. (3H)Kainic acid ((3H)KA) in a volume of 0.1 ml, various 
concentrations of the radioligand, displacers and drugs were used. 
During preparation and incubation, the tubes were kept in an ice-water 
bath maintained at A C .  Incubation was prolonged for 60 minutes and 
terminated by filtration under vacuum with GF/B Whatman filters [q]
3.7 cm in diameter. The filters were rinsed twice with 5 ml of GDW and 
then counted In 15 ml of ACS solution. Radioactivity trapped on the 
filters was determined by liquid scintillation spectroscopy of the 
samples solubilized in 15 ml of ACS at a counting efficiency of 34%. 
Total specific binding of (3H)KA was defined as the difference between 
total binding with radioligand alone and non-specific binding measured 
in the presence of 0.1 mM unlabeled kainic acid (Simon, et aj.., 1976).
2. SATURABILITY OF SYNAPTIC MEMBRANE KAINIC ACID RECEPTORS- The 
characteristics of the binding of (3H)KA to synaptic membranes with 
increasing concentrations of the radioligand were determined by 
incubation of 1 ml of the final homogenate (0.512 mg protein/ml) for 60 
minutes at 4 C as described above in 1C. Radioligand concentrations
ranged from 1.25 to 200 nM.
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3. (3H)KAINIC acid high and low affinity binding sites AND IC50 
CALCULATIONS -
a. To characterize separately the binding to high affinity and low 
affinity receptor binding sites, advantage was taken of the fact that 
the radioligand dissociates slowly (Tjy2 " 90 minutes) from high 
affinity sites but nearly instantaneously from low affinity sites 
(London & Coyle, 1979). After 55 minutes of incubation of the membranes 
with (3H)KA, 200 mmoles of unlabelled kainic acid were added to some 
experimental tubes to bring the final concentration of unlabeled ligand 
to 0.1 mM. After 5 minutes of additinal incubation, the tubes were 
filtered and the binding of (3H)KA was measured.
The addition of 200 mmoles of unlabeled ligand 5 minutes prior to 
filtration totally displaced the radioligand from low affinity binding 
sites, but did not affect the non-specific binding; thus the difference 
between binding in this preparation and those incubated in the presence 
of radioligand alone represents binding to low affinity receptor sites. 
The difference between binding occurring in the continuous presence of 
unlabeled ligand (non-specific) and that occurring with the 5 minute 
exposure to an excess of unlabeled ligand represents binding to high 
affinity receptor sites.
b. Specificity of (3H)KA binding to forebrain synaptic membranes was 
demonstrated by comparing the effects of various analog compounds on 
the binding of (3H)KA with the membranes. One ml of homogenate was 
incubated with 40 nM (3H)KA In a total volume of 2 ml, in the same
conditions described above in 1C. Drugs, and ions such as Ca++ and Mg++ 
were added to the tubes for competing binding. The filters containing 
the trapped radioactivity were washed and dried as already described 
and counted in a liquid scintillation spectrometer [p]. Simultaneous 
experiments for high and low affinity binding sites were conducted 
for different concentrations of the drugs used.
4. SCATCHARD ANALYSIS - Linear regression of the data was performed 
by Scatchard analysis. Estimates of the total number of sites (Bmax), 
and the equilibrium dissociation constant (K^) for the ligand-receptor 
reaction were determined from the saturation isotherms. The Scatchard 
program is part of a software package called LIGAND (Munson & Rodbard,
1980).
5. NON-LINEAR ANALYSIS - A weighted non-linear program (Metzer & 
Weiner, 1984) for one and multiple sites models was used to assess the 
presence of multiple (^H)KA binding sites.
6 . STATISTICAL ANALYSIS- Comparisons of binding data between control 
and treated groups were made by Student's t-test. Differences were 
considered significant when p < 0.05.
7. INTER- AND INTRA-ASSAY COEFFICIENTS OF VARIATION - To assess the 
precision of the method, the interassay and the intraassay coefficient 
of variation were calcutated using standard statistical techiques.
8 . DEGRADATION OF THE RADIOLIGAND - To minimize decomposition of
(3H)KA solution at 1 mCi/ml, stocks of the solution were stored at 2 C 
and used as soon as possible after shipment from Amersham [r],
D. DATA OBTAINED - The following parameters were measured from the
following (3H)KA experiments:
1 - ®max an<* from the following saturation curves:
a) In Ca++ free Tris buffer.
b) In Ca++ free Tris buffer and U-50488H.
c) In the presence of Ca++ ions.
d) In the presence of Ca"1-*" ions and U-50488H.
e) In the presence of Cl" ions.
f) In the presence of Cl" ions and U-50488H.
g) In the presence of Ca"*"*" and Cl" ions.
h) In the presence of Ca-*"*- and Cl" ions and U-50488H.
2. IC50 values:
a) In Ca^-free Tris buffer.
b) In Ca++ free Tris buffer and several concentrations of
1 -glutamate
c) In Ca-1-1" free Tris buffer and several
concentrations of U-50488H.
d) In the presence of Ca++, Cl" ions, and U*50488H.
e) In the presence of Ca++ and U-50488H.
Ill 2-(3H)-DEOXY-D-GLUCOSE UPTAKE IN VARIOUS MOUSE BRAIN 
REGIONS
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A. LABELED 2-DEOXYGLUCOSE
1. The radiolabeled 2-(3H)-deoxy-d-glucose ((3H)DG) used in all
uptake studies was purchased from DUPONT* NEN Research Products [t]. 
The (3H)DG had a specific activity of 7,1 curies per mmole of
2-deoxy-d-glucose at a concentration of 1.0 microcurie/ml of a 1:9
water:ethanol solution.
/
B. (3H)DG uptake in various mouse brain regions
1. ANIMALS - Upjohn CF-1 male mice [c] (18-25 g) were used to 
determine the uptake of (3H)DG in the hippocampus, corpus striatum and 
septum (Montemurro & Dukelow, 1972).
2. (3H)DG UPTAKE ASSAY - (3H)DG uptake was evaluated according to the
following schedule: saline, KA and/or U-50488H were administered
subcutaneously (s.c.) at time zero. Fifteen minutes later 10 
raicrocuries/20 gm of (3H)DG (Appendix 3) in saline was injected 
intravenously (i.v.) and the distribution and uptake allowed to take 
place for 30 minutes while the mice were housed in an isolation box 
supplied with white noise control to standardize sensory stimuli. 
Individual mice were then decapitated and the brain regions quickly 
dissected out and weighed in preweighed scintillation vials containing
0.5 ml Protosol [u]. The vials were tightly sealed with Teflon liners 
[v] and maintained at 50 C overnight.
Each sample was neutralized with 100 microliters of glacial acetic 
acid per ml of Protosol. ACS (15 ml) [1] was added and radioactivity of 
the samples was counted with a liquid scintillation spectrometer [p]. 
The radioactivity was recorded as CPM/mg of tissue.
C. DATA OBTAINED - Uptake was measured from the following groups: a) 
saline control, b) KA control, and c) KA and U-50488H; data were 
expressed as both CPM/mg and percent of control.
D. STATISTICAL ANALYSIS- Comparisons of uptake data between control 
and treated groups were made by Student's t-test. Differences were 
considered significant when p< 0.05.
IV THE EFFECTS OF SUBCUTANEOUS U-50488H ADMINISTRATION ON 
KAINIC ACID LESIONS IN THE MOUSE HIPPOCAMPUS
A. DRUGS
1. KAINIC ACID - The kainic acid used in this morphometry study was 
purchased from Sigma Chemical Company [sj. The compound was 
administered in saline solution at a concentration of 0.04 
micrograms/microliter.
2. U-50488H - The compound was generously donated by Dr. Phillip F. 
Von Voigtlander, The Upjohn Company [w]. U-50488H was used in a saline 
solution at a concentration of 0 . 0 1 gm/ml.
3. ANESTHETIC - Methoxyflurane was purchased from Pitman-Moore, Inc 
[x].
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B. ANIMALS - Charles River CF-1 male mice (18-20 g) ]c] were used in 
this experiment. The mice were housed as groups, with and water and 
food [ab] provided ad libitum.
C. EXPERIMENTAL DESIGN - The mice were assigned to 4 groups of n— 
6-7. Group 1 was a saline control and mice were given saline solution
at all times. Group 2 was a positive control and mice received saline
and KA. Group 3 was a negative control and mice received U-50488H and 
saline. Group 4 received U-50488H and KA. Behavior was observed for one 
hour after the administration of drugs and once daily for the next 4
days. All mice were sacrificed on day 4.
D. PRETREATMENT - The pretreated groups were given saline or 
U-50488H 100 mg/Kg, s.c. 30 minutes before KA or saline administration.
E. KAINIC ACID INDUCED LESIONS - Mice were given free-hand
intracerebroventricular (i.c.v.) injections of 0.08 micrograms KA 
(total dose) in saline. The mice were allowed to recover for 4 days and 
water and food (Appendix 4A) provided ad libitum.
F. COLLECTION OF SAMPLES
a. PERFUSION - Animals were anesthetized with methoxyflurane, the 
chest cavity was opened and saline was injected directly into the heart 
to flush the circulatory system. Fixation of the brain was accomplished 
by vascular perfusion of a buffered solution containing glutaraldehyde
and formaldehyde (Karnovsky's fixative) (Appendix 4B) diluted 1:20 with
0 . 1 M cacodylate buffer, followed by a more concentrated solution of 
the same buffer.
b. FIXATION - The fixative was delivered rapidly after saline and
allowed to flow for 5 minutes. The pressure for the perfusion was kept 
constant by suspending the bottle containing the fixative and washing 
out solution at a height of about 60 cm. Care was taken to ensure that 
no air bubble entered the vascular system. Following perfusion, soft 
tissues were removed from the outer surface of the skull; the latter 
was immersed in Karnovsky's fixative for at least 12 hours after 
removal. The intact brain was removed by careful dissection of the 
bones of the calvarium; brains were left in fresh fixative for an 
additional period of approximately 8 days.
G. HISTOLOGY* The cerebellum was removed from the cerebrum with a
transverse section through the midbrain at the level of the corpora 
quadrigemina. Blocks of cerebrum were prepared for embedding with a 
transverse section at the level of the optic nerve; the cerebellum was 
sectioned in a similar manner at the level of the pons (Figure 3). 
Trimmed blocks of brain were embedded in parafin and five serial 
sections, each 6 micron in thickness, were cut from the trimmed 
surfaces of each block with a rotary microtome [y] . Resulting tissue 
sections were stained with hematoxylin-phloxine-eosin. The staining 
procedure was the same for all batches of slides. The sampling 
technique was adjusted so that the cytoarchitecture of the hippocampus 
wasthe same in all slides.
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Figure 3. Illustration indicating sites of brain sections
taken for histopathological examination.
r
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H. HISTOPATHOLOGY
1. DESCRIPTION OF KA LESIONS - Histopathologic changes were 
restricted to the neurons and associated neuropil of the granular layer 
in the CA3 region of the hippocampus. Extensive degeneration and 
necrosis of neurons resulted in dark, shrunken cell bodies and 
vacuolization of the neuropil associated with pyknotic neurons.
2. PHOTOGRAPHIC DISPLAY- Fig 4 shows the five levels of the 
hippocampus where KA lesions were quantitated by image analysis. The 
effects of 100 mg/Kg U-50488H are illustrated in Fig 5,
I. IMAGE ANALYSIS
1. ADQUISITION OF IMAGES - The video images were acquired using a 
Magiscan Image Analysis system [z] incorporating a Dage black and white 
video camera mounted on a Nikon Fluophot microscope fitted with a 20x 
objective lens. All operations of the image processor were controlled 
by the computer.
2. IMAGE PROCESSING - The computer digitazed the signal to 6 -bit 
resolution and stored it for image processing. The image processing 
routine was optimized with a program called "MENU" supplied with the instrunent.
Using "MENU" a sequence of grey image and binary operations was 
performed which conveniently allowed measurement of vacuolized areas. 
Specifically, it was found that a Gausian transform of the image 
followed by edge enhancement permitted segmentation of vacuoles from
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Figure 4. KA-induced lesions (arrows) in the mouse CA3 region
of the hippocampus. GD- gyrus dentate; CA1, CA2, CA3 
and CA4 — CAl, CA2, CA3 and CA4 regions of the hippocaipus. 
H and E stain. 20X.
U-50488H 
+KA '
100X 160X
Figure 5. Effect of U-50488H on kainic acid induced lesions in
the mouse hippocampus.
surrounding cells. Under normal circumstances no binary image 
enhancement was necessary. Using this program the area of each vacuole 
was measured independently and the total area of the field was 
determined automatically. Interactive editing permitted rejection of 
unwanted or inappropiate features. Bright regions of the output display 
showed where there was absence of neuronal cell body (vacuolization) 
within the granule cell layer of the hippocampus.
The image processing procedure was designed to quantify the area 
occupied by vacuoles obtained from each slide in a frame of 2 0 0x2 0 0  
pixels (Quantitation), to remove the inappropiate areas such as blood 
vessels, and artifacts of histological processing, (Editing), to 
calibrate the measured image (pixels/mm) (Calibration), to subtract 
unwanted background, and to scale the resulting image in statistically 
interpretable manner. On control slides, this procedure yielded an 
image of regional bright area variability, that is, extracellular 
noise. In the treated animals, this image reflected activity associated 
with injury to the neuronal cells plus extracellular space. Comparison 
of the proportion of vacuoles between the different groups revealed 
those groups in which vacuolization was significantly enhanced or decreased 
by previously administered KA, drugs or combinations of both.
3. QUANTITATION - For each slide examined, the area of vacuoli­
zation in the granule cell layer of area CA3, where most of the 
lesions were found, was measured with a Joyce Loebl Magiscan 2 system 
[z] connected to adequate monitoring and recording equipment (ie. 
microscope, camera and matrix printer). These measurements provided
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the basis for the final estimation of the vacuolization profile
produced by KA.
J. STATISTICAL ANALYSIS - The data was analyzed by the one-way 
analysis of variance by pairwise comparison of treatment means using 
Fisher's Least Significant Difference (LSD). The Kruskall Wallis test 
was used to analyze the data and to confirm the results of the 
parametric analysis. P values of <0.050 indicate significat differences 
between the groups.
RESULTS
I. 4 5 Ca++ UPTAKE TECHNIQUES
A. SYNAPTOSOMES
1. PROTEIN COMPOSITION OF SYNAPTOSOMAL PREPARATION- The protein 
concentration of the final synaptosomal suspension was between 1.0- 5.0 
mg/ml.
2. MORPHOLOGICAL CONTROL- Examination of the equilibrated
synaptosomes by electron microscopy was undertaken to determine the 
homogeneity and ultrastructural integrity of the cellular material 
collected. The identifiable subcellular components included 
mitochondria, morphologically intact synaptosomes, myelin, and 
unidentified membranous material (Figure 6 ).
B. 4 5 Ca++ UPTAKE STUDIES
1. EFFECTS OF TIME, K+ ION, PROVERATRINE DEPOLARIZATION AND Na+ ION 
ABSENCE- Uptake of calcium by the synaptosomes was increased with time 
in both control synaptosomes and those depolarized by substitution of 
40 mM external K+ on an equimolar basis for Na+ . The time course of 
this accumulation is shown in Figure 7. For an incubation time of 8 
sec, the amount of uptake during depolarization was 1.7 times greater
41
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6 . Electron micrograph of rat forebrain synaptosomes 
prepared on Ficoll gradients. Synaptosomes (S), and 
myelin (my). Bar - 500um; OSO4 -UL 65,000x.
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Figure 7.
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than that in 5.6 mM K+ buffer. Net Ca++ uptake was the difference 
between control and depolarized uptake. The data in Table 1 indicate 
that the depolarizing concentrations of K+ resulted in reliable 
increases in Ca++ uptake. Proveratrine was also able to depolarize the 
synaptosomes as shown in Table 2. Depolarization has been shown to have 
an inhibitory effect on Na+/Ca++ exchange (Blaustein e£ al, 1974). This 
exchange is electrogenic in nature with respect to Na+ (exchanging 3 to 
4 Na+ per Ca"*"*") and bidirectional. A reduction of Ca++ efflux via 
Na+/Ca++ exchange has been observed previously as a result of reduction 
of external Na+ (Blaustein & Oborn, 1975).
To eliminate the Na+ dependent processes contributing to the Ca++ 
accumulation, the Ca++ uptake was measured using a buffer in which 
choline was used to substitute for external sodium (Appendix 1C). In a 
Na+-free buffer the Ca++ uptake of depolarized synaptosomes at 8 sec 
was not increased when compared to the Na+ control (Figure 8 ), (Table 
3A) . The time course showed that at 60 sec the net uptake of depolarized 
synaptosomes was the same as that of the K+ control (Figure 8 ).
In the presence of external Na+ (136 mM) the net Ca++ uptake of the 
depolarized synaptosomes at 8 sec was 3 . 8 times that of the control at 
60 sec (Table 1A).
The uptake kinetics of ^Ca"*-*" have been previously described as 
having two phases, fast and slow, kinetically characterized by 
Gripenberg et al, (1980), and Blaustein (1975). The difference between 
these two phases is the decrease in the
Table 1. Effects of Time and K+ Depolarization on 
■^’Ca++ Uptake by Synaptosomes.
^ C a ++ uptake 
CPM(+/-S.D.)
Control( 5 . 6mM K.+> Depolarized(40 mM K.+^
Incubation 
Time (sec)
8
30
60
1684+/-77 
ND
2512+/-22*
2884+/-289*
S283+/-328**
7068+/-395**
Net Uptake(CPM)
1200
ND
4556
Prior Depolarization 
8 Control 632 +/- 93 361 +/- 18**
8 Blank 167 +/- 19 115 +/- 8
* p <0.01 compared to control (5.6 mM K+). n-3.
** p <0.01 compared to control (40 mM K+). n-3. 
ND- not determined
Table 2. Effect of Proveratrine on Ca** Uptake by Rat Brain
Synaptosomes.
A. Effect of proveratrine in 5.6 mM K+ .
^Ca'H' uptake 
CP_M{+/- S.D.)
Control® 
Proveratrine 10 
Proveratrine 10 
Proveratrine 10"^M
1690 +/- 131* 
2328 +/- 182** 
1781 +/- 192 
1617 +/- 75
a K+ .40 mM control- 3989 +/-241 CPM(+/-S.D.).
* p<0.01 compared to 40 mM K+ control, n-4.
** p<0.01 compared to 5.6 mM K+ control, n-4.
B. Effect of proveratrine on depolarized synaptosomes.
^Ca** uptake 
CPMfX+Z- S.D.'I 
K— 5.6 mM K— 40 mM
Control 861 +/- ^3 1656+/-139*
Proveratrine 10“5M 1076 +/- 52* 1901+/-191**
* p<0.01 compared to 5.6 mM K+ control, n-4.
** p<0.05 compared 40 mM K+ control, n-4.
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Table 3. Effect of Replacement of Na+ Ions with Choline on 
4 -’Ca++ Uptake by Synaptosomes in the Presence of 
U-50488H.
A. Time course of 4 -*Ca++ uptake in the presence of choline.
1. Uptake at rest a .
4 5 Ca++ uptake 
CPM(+/-S.D.)
Control 8 sec 1486+/- 97
Control 1 min 3486+/-182
Control 3 min 4194+/-218
Control 5 min 4708+/-145
a K+ 40 mM 8 sec control- 1531+/-52 (CPM+/-S.D.).
2. Uptake in depolarizing buffer b .
4~*Ca uptake 
CPM(+/-S.D.)
Control 8 sec 2206+/- 129
Control 30 sec 3563+/- 250
Control 1 min 4280+/- 60
b K+ 5.6 mM 8 sec control- 2590+/-128 (CPM+/-S.D .).
B. Effects of U-50488H on 4 -’Ca++ uptake in the presence of 
choline.
1 . 8 sec incubation time.
^ C a H  uptake
CPMf+Z-S.D^
40mM K+t>
Control
U-50488H 10_4M 
U-50488H 10'5M 
U-50488H 10-6M 
U-50488H 10-7M 
Filter Blank
1531+/- 52
1894+/- 122 * 
1454+/- 114 
1668+/- 1 2 0 * 
1415+/- 193 
118 +/- 14
b K+ 5.6 mM control- 1486+/- 97 CPM(+/-S.D .).
* p<0.01 compared to 40.0 mM K+ control, n—3.
velocity of the uptake. The uptake values for up to 30 sec are taken to 
represent the fast phase, and after 60 sec the late slow phase. As 
shown by Gripenberg al, (1980), there is better linearity of the 
double reciprocal plots of the rates of calcium versus the 
concentration of calcium for the depolarized medium and for the fast 
phase. Thud, we choose the 8 sec incubation time as representative of 
the fast phase and designed subsequent experiments using this 
incubation time.
These results showed our system to be an operational system, in 
agreement with current publications, and that increases in uptake in 
depolarized synaptosomes are a reliable measure of Ca++ flux. We also 
showed that in the absence of external Na+ the net Na+-dependent Ca++ 
uptake was inactivated as a result of depolarization. Prior 
depolarization of synaptosomes showed inactivation of the K+ stimulated 
calcium uptake (Table IB). This effect has been observed by Lee & Tsien 
(1983).
2. EFFECTS OF THE CALCIUM CHANNEL AGONIST, BAY K 8644 ON 
K+-STIMULATED CALCIUM UPTAKE -A significant decrease caused by BAY K 
8644 was observed on calcium uptake by rat brain synaptosomes at rest 
and under depolarizing conditions. The uptake at 60 sec was decreased 
when tested with concentrations between 10'^ and 1 0 " M at rest and 
with 10"^M in high K+ concentration buffer (Table 4B). The uptake at 8 
sec was not altered at rest or under depolarizing conditions (Table 
4A) .
Table 4. Effect of BAY K 8644 on Ca‘t“*‘ Uptake by Rat Brain
Synaptosomes.
A. 8 sec incubation time.
^^Ca~H ' uptake 
CPMf+/- S.D.1)
K+ 5.6 mM K+ 40mM
Control 880 +/- 153 1325 +/■ HO*
BAY K 8644 10*4M 932 +/- 83 1407 +/- 61
BAY K 8644 10'5M 957 +/' 268 1320 +/- 189
BAY K 8644 10 ’6M 812 +/- 94 1320 +/- 57
BAY K 8644 10'7M 829 +/' 58 1328 +/- 136
BAY K 8644 10'8M 805 +/- 70 1304 +/- H 7
B. 60 sec 4 5ca++ incubation time.
^ C a ++ uptake 
CPMC+/- S .D .^
K+ 40 mM 
6195 +/’ 156 * 
5031 +/* 145 ** 
5438 +/- 871 
5927 +/- 291 
5084 +/- 313 
5753 +/- 183 
138 +/- 36
* p<0.01 compared to K+ 5.6 mM control.
** p<0.01 compared to K+ 40 mM control. 
n-3.
Control
BAY K 8644 10*4M 
BAY K 8644 10*SM 
BAY K 8644 10*6M 
BAY K 8644 10*7M 
BAY K 8644 10*8M 
Filter Blank
K 5.6 mM 
3084 +/* 23
2377 +/- 160 * 
2883 +/- 103 * 
2937 +/- 163 
3105 +/- 80
3170 +/- 38 *
164 +/- 35
3. INHIBITION OF K+-STIMULATED CALCIUM UPTAKE BY CALCIUM
CHANNEL BLOCKERS- The K+-induced increase in Ca++ uptake was sensitive 
to antagonism by verapamil at a concentration of 10'^M. This Ca++ 
antagonist was effective in attenuating the depolarization-induced Ca++ 
accumulation only during the fast phase of the uptake (TABLES 5A, 5B & 
6 ). Verapamil, a benzeneacetonitrile, is a calcium-blocker which acts at 
voltage sensitive calcium channels (Turner & Goldin 1985; Schramm, et 
al., 1986).
4. INHIBITION OF K+-STIMULATED CALCIUM UPTAKE BY U-50488H -
At rest, no antagonism of the calcium uptake was observed in the 
presence of U-50488H. In contrast, the K+-induced increase in Ca++ 
uptake was antagonized by U-50488H with 8 sec incubation (Table 5A & 
5B).
This decrease was concentration-related and of the same magnitude as 
that of verapamil and nifedipine, another calcium channel blocker 
(Table 6 ).
5. NALOXONE AND MORPHINE EFFECTS ON K+-STIMULATED CALCIUM UPTAKE- A 
high concentration (10"-*M) of naloxone blocked calcium uptake (Table 
6 ). Naloxone at concentrations of 10’  ^and lower failed to decrease the 
Ca++ uptake and to block the reduction in Ca"*"1" uptake induced by 
U-50488H. Morphine failed to significantly alter the K+-stimulated Ca++ 
uptake at concentrations ranging from 10 to 10 "®M and under two 
different experimental conditions, in calcium-free and calcium
Table 5. Effect of Verapamil HCl and U-50488H upon Ca++ Uptake
by Rat Brain Synaptosomes.
A. 8 sec -^’Ca++' incubation
K+.
Control 847
Verapamil HCl 10’6M 790
U-50488H 10' 5 M 815
Filter Blank 128
B. 60 sec ^ C a ++ incubation
Control 2512
Verapamil HCl 10_6M 2509
U-50488H 10‘5 M 2423
Filter Blank 138
* p<0.01 compared to 5.6 mM
** p<0.01 compared to 40 mM 1 
n-3.
-^*Ca~t~+ uptake 
CPM(+/- S.D.'t
5.6 mM K+ 40mM
+/- 72 1949 +/- 50*
+/- 50 1856 +/- 59**
+/- 43 1766 +/- 6 6**
+/- 24 162 +/- 29
+/- 22 4343 +/- 208*
+/- 123 4400 +/- 193
+/- 216 4310 +/* 242
+/- 12 148 +/* 7
K+ control. 
:+ control.
Table 6. Further Evaluation of the Effects of U-50488H upon
Uptake by Rat Brain Synaptosomes.
A. 8 sec ^Ca"H‘ incubation
^5ca++ uutake
CPMf+Z-S.D.’*
K+ 40mM
Control3 2832 +/- 287*
U-50488H 10'5M 2032 +/- 232**
U-50488H 10*6M 2410 +/- 96**
U-50488H 10'7M 2661 +/- 96
Verapamil HCl 10*^M 1896 +/- 106**
Nifedipine 10‘^M 2474 +/- 76**
Naloxone HCl 10"->M 2253 +/- 8 8**
a K+ 5.6 mM control- 1215+/-123 CPM(+/-S.D.)
B. 8 sec -^’Ca++ incubation
UDtake
CPM(+/-S.D.
K+ 40mM
Control^ 2824 +/- 99*
Naloxone HCl 10‘7M 2912 +/- 151
Naloxone HCl 10*7M and
U-50488H 10'6M 2621 +/- 1 0 0**
b K+ 5.6 mM control- 1452+/* 82 CPM(+/-S.D.)
* p<0.01 compared to 5.6 mM K+ control, n-4.
** p<0.01 compared to 40 mM' K+ control, n-4.
supplemented medium, with 1 and 1 0 minute incubations, respectively 
(Table 7A & 7B).
6 . EFFECTS OF EXCITATORY AMINO ACIDS ON K+-STIMULATED CALCIUM UPTAKE IN 
THE PRESENCE OF Ca++ AND Mg++ IONS -Kainate (KA), and 
N-methyl-D-aspartate (NMDA) did not significantly alter Ca++ uptake by 
rat brain synaptosomes in a Ca^-free buffer at rest or under 
depolarizing conditions. Likewise, the presence of Ca++ ions at a 
concentration of 2.2 mM and Mg"*-*- ions at 1.3 mM were ineffective 
(Tables 8 and 9) .
1-Glutamate markedly decreased the Ca"*"*" uptake at rest and in the 
depolarizing buffer. The data in Table 9 demonstrate that the absence 
of Mg-*-* ions was not necessary for this effect on Ca'H " uptake to be 
present in our system and that it was only seen with concentrations in 
the range of 1 0 to 10_ M^.
II. KAINIC ACID BINDING ASSAY
A. CRUDE SYNAPTIC MEMBRANE FRACTION
1. PROTEIN DETERMINATION - Approximately 0.5-0.6 mg protein/ral were 
used in all assays. The synaptic membrane protein levels were 
quantitated by the Bio-Rad method (Bradford, 1976).
2. MORPHOLOGICAL CONTROL- Examination of the synaptic membranes by 
electron microscopy was undertaken to determine
Table 7. Effect of Morphine on Ca++ Uptake by Rat Brain
Synaptosomes.
A. 60 sec drug incubation, 0 Ca"*-** in preincubation medium
Ca'1"1' uptake 
CPM(+/~ S.D .^
Control3
Morphine SO4 10"6M 
Morphine SO4 10'7M 
Morphine SO4 10“ ®M
K+ 40mM 
1300 +/- 
1290 +/- 
1297 +/- 
1238 +/-
68*
101
59
101
a K+ 5.6 mM control- 543+/-39 CPM(+/-S.D.).
B. 10 min drug incubation, 2.2 mM Ca++ in preincubation
medium.
Control^
Morphine SO4 10“6M 
Morphine SO4 10’^ M 
Morphine SO4 10“®M
-^*Ca++ uptake 
CPM(+/-S.D.) 
K+ 40mM 
943 +/- 81*
939 +/- 92
930 +/- 44
852 +/- 74
K+ 5.6 mM control- 508+/-44 CPM(+/-S.D.).
* p<0.01 compared to 5.6 mM K+ control, n-3.
Table 8. Effect of Excitatory Amino Acids on Ca++ Uptake
by Rat Brain Synaptosomes.
Control3  
KA 10'4M 
KA 10'5M 
KA 10'6M 
KA 10'7M 
KA 10"8M 
Filter Blank
^ C a ++ uptake 
CPMf+/- S.D.) 
K+ 5.6 mM
1747 +/- 118 
1625 +/- 26 
1659 +/- 48 
1641 +/- 116 
1636 +/- 103 
1658 +/- 100 
76 +/- 10
a K+ 40 mM control-3164+/-252 CPM(+/-S,D .).
^Ca"H " uotake 
CPM(+/- S.D.1 
K+ 5.6 mM
Control 1443 +/- 49
NMDA 10'5M 1694 +/- 144
NMDA 10'6M 1729 +/- 91
NMDA 10*7M 1721 +/- 111
Filter Blank 192 +/- 64
-^’Ca++ uotake 
CPM(+/- S,D ,)
K+ 5.6 mM K+ 40 mM
Control 3036 +/- 166 7126 +/- 107*
L-Glutamate 10*2M 773- +/- 90* 701 +/- 20**
L-Glutamate 10' 3M 2984 +/- 340 5654 +/- 550**
Filter Blank 192 +/- 64 269 +/- 80
* p<0.05 compared to 5.6 mM K+ control, n-4.
** p<0.05 compared to 40 mM K+ control, n-4.
Table 9. Effect of Excitatory Amino Acids and Mg'*-*" ions on
Ca"*"+ Uptake by Rat Brain Synaptosomes.
A. Effect of MgH
Control 
Mg++ 1.3 mM 
Filter Blank
ions upon ■^*Ca++ uptake
^ C a -"  uptake 
CPMf+Z-S.D.)
K+ 5.6 mM
1443 +/- 49 
1143 +/- 49 
192 +/- 64
K 40mM
1848 +/- 109* 
1637 +/- 84**
269 +/• 80
B. 45Ca++ uptake in Mg"1
Control 
KA 10* 3M 
KA 10*4m 
KA 10*5M 
KA 10*6M 
Filter Blank
Control 
1-Glutamate 
1-Glutamate 10 "^M 
1 -Glutamate 1 0 *3M 
1 -Glutamate 1 0 *^M 
Filter Blank
10*3M 
)-4j
4- 5k
Control 
NMDA 
NMDA 
NMDA 
NMDA 
Filter Blank
10*3M
10*4M
10*5M
10*6M
'-free buffer.
45Ca++ uptake 
CPMf+/-S.D-
K+ !5.6 mM K+ 40mM
1443 +/- 49 1848 +/- 109*
674 +/- 13* 1446 +/- 31
1375 +/- 67 1900 +/- 149
1261 +/- 81* 2316 +/- 57
1237 +/- 34 2026 +/- 72
192 +/- 64 269 +/- 80
1443 +/- 49 1848 +/- 109*
410 +/- 4* 558 +/- 21
1078 +/- 47 1774 +/- 196
1188 +/- 12 1934 +/- 109
1223 +/- 21 1652 +/- 153
192 +/- 64 269 +/- 80
1443 +/- 49 1848 +/- 109*
598 +/- 26* 1265 +/- 63
1312 +/- 57 1826 +/- 69
1227 +/- 38 2023 +/- 62
1138 +/- 52 1894 +/* 99
192 +/- 64 269 +/- 80
* p<0.05 compared to 5.6 mM K+ control, n-4.
** p<0.01 compared to 40 mM K+ control, n-4.
the homogeneity of the cellular material collected. The identifiable 
subcellular components included myelin and unidentified membranous 
material (Figure 9).
B. KAINIC ACID BINDING ASSAY TECHNIQUE
1. SATURABILITY • The bound radioligand was plotted against the free 
radioligand at concentrations ranging from 1.5 to 200 nM. The specific 
binding data were obtained by using data expressed in CPM. Total 
specific binding of (3H)KA was defined as the difference between the 
total binding with radioligand alone and nonspecific binding measured 
in the presence of 0.1 nM unlabeled kainic acid. Total binding and non-specific 
binding curves increased linearly with increasing concentrations of the 
radioligand (Figure 10).
a. BINDING IN Ca++-FREE BUFFER - The specific binding of (3H)KA to 
forebrain synaptic membranes was saturable with a receptor density 
maximum (Bmax) of 1.28 +/- 0.008 pmol/mg protein, and a dissociation 
constant (Kj) of 32.93 +/- 2.8 nM in the Ca^-free buffer. To confirm 
saturability, a double reciprocal plot of 1/bound KA versus 1/free KA 
was constructed. Linear regression analysis of these points yielded a 
y-intercept and a x-intercept supporting the saturability of this 
system (Table 10 & Figure 11).
Figure 9. Electron micrograph of mouse synaptic membranes. 
Morphologic control. Myelin (ray) 65,000x.
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Figure 10. Saturation of (^H)KA binding to rat forebrain synaptic 
membranes in Ca^-free buffer as a function of 
radioligand concentration. ( H  ) Total Binding; ( □  )
Specific Binding; (#) Non-Specific Binding.
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Table 10. Kainic Acid Binding Assay. Double Reciprocal Plot Data
Intercept
A. Tris/Acetate buffer
Ca++ free 1.050
Ca++ 1.25 mM added 0.398
Ca++ 1.25 mM and 
U-50488H 10’ 5 M 0,538
Ca++ 2.5 mM added 0.676
B. Cl" containing buffer
Ca++ free 2.390
Ca++ 1.25 mM added 1.980
Ca++ 2.5 mM added 2.820
Ca++ 2.5 mM and 
U-50488H 10" 5 M 1.646
-0.076
-0.024
-0.037
-0.045
-0.016
-0,049
-0.182
-0.084
b. BINDING IN THE PRESENCE OF C1‘ IONS- The specific binding of (3H)KA 
to forebrain synaptic membranes was saturable with a receptor density 
maximum (Bmax) of 1.30 +/- 0,01 pmol/mg protein, and a dissociation 
constant (K(j) of 22.32 +/- 1.0 nM in the Tris/HCl buffer. To confirm 
saturability, a double reciprocal plot of 1/bound KA versus 1/free KA 
was constructed. Linear regression analysis of these points yielded a 
y-intercept and a x-intercept supporting the saturability of this 
system (Table 10).
c. BINDING IN THE PRESENCE OF Ca++ IONS- The specific binding of
(3H)KA to forebrain synaptic membranes in a Tris/Acetate buffer was
saturable with a receptor density maximum (Braax) of 1.76 +/- 0.1
pmol/mg protein, and a dissociation constant (K^) of 33.72 +/- 2.0 nM 
in the presence of 1.25 mM Ca"H ". To confirm saturability, a double 
reciprocal plot of 1/bound KA versus 1/free KA was constructed. Linear 
regression analysis of these points yielded a y-intercept and a 
x-intercept supporting the theory of the saturability of this system 
(Table 10). In the presence of 2.5 mM Ca++, the specific binding of
(JH)KA to forebrain synaptic membranes was saturable with a receptor
density maximum (Bmax) of 1.80 +/- 0.1 pmol/mg protein, and a 
dissociation constant (K^) of 61.24 +/- 3.0 nM in the 2.5 mM Ca"*""**
buffer. To confirm saturability, a double reciprocal plot of 1/bound KA 
versus 1/free KA was constructed. Linear regression analysis of these 
points yielded a y-Intercept and a x-intercept supporting the theory
VX(Ht) Punoa/l
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Figure 11. Double reciprocal plot of (^H)KA binding to mouse 
forebrain synaptic membranes in a Ca++-free buffer.
Table 11. Kainic Acid Binding Parameters for Mouse Forebrain 
Membranes.
A. Tris/Acetate buffer 50 mM, pH-7.1.
1. Ca++ free buffer n-4 
Parameter Bmax
(pM/mg protein)
Weighted average 1.28 +/- 0.01 
Intra Assay % CV 23.8
Inter Assay % CV 6.4
2 . Ca++ added
a. 1.25 mM Ca++ n-2
Weighted Average 1.76 +/- 0.10
Intra Assay % CV 8.1
Inter Assay % CV 8.5
b. 2.50 mM Ca++ n-3
Weighted Average 1.80 +/- 0.10
Intra Assay % CV 14.1
Inter Assay % CV 21.0
Tris/HCl buffer 50 mM, pH-7.1.
1. Cl- ions buffer n-4
Parameter Bmax
(pM/mg protein)
Weighted average 1.30 +/- 0.01
Intra Assay % CV 12.2
Inter Assay % CV 21.5
2. Ca++ added
a. 1.25 mM Ca++ n-1
Weighted Average 2.68 +/- 1.42
b. 2.50 mM Ca++ n-2
Weighted Average 1.59 +/- 0.20
Intra Assay % CV 30.1
Inter Assay % CV 42.4
Kd
(nM)
32.93 +/-3 
39.9 
42.7
33.72 +/-2 
9.8 
49.0
61.22 +/-Z 
9.5 
32.5
Kd
(nM)
22.32 +/-1 
13.3 
49.9
127.40 +/- 81
105.0 +/-U 
5.8 
82.6
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of the saturability of this system (Figure 11 & Tables 10 & 11).
d. BINDING IN THE PRESENCE OF 03++ AND Cl" IONS- The specific binding 
of (^H)KA to forebrain synaptic membranes was saturable with a 
receptor density maximum (Bmax) of 2.68 +/- 1.42, and a dissociation 
constant (K^) of 127.40+/-81 in the 1.25 mM Ca++ buffer. To confirm 
saturability, a double reciprocal plot of 1/bound KA versus 1/free KA 
was constructed. Linear regression analysis of these points yielded a 
y-intercept and a x-intercept supporting the theory of the saturability 
of this system (Tables 10 & 11 & Figure 12).
In the presence of 2.5 mM Ca*-1", the specific binding of (^H)KA to 
forebrain synaptic membranes was saturable with a receptor density 
maximum (Bmax) of 1.59 +/- 0.17, and a dissociation constant (Kj) of 
104.63+/-81 In the 2.50 mM Ca++ buffer. To confirm saturability, a 
double reciprocal plot of 1/bound KA versus 1/free KA was constructed. 
Linear regression analysis of these points yielded a y-intercept and a 
x-Intercept supporting the theory of the saturability of this system 
(Tables 10 & 11).
2. SPECIFICITY OF BINDING
a. NON-LABELEDED KAINATE AND 1-GLUTAMATE- Unlabeled kainic and 1- 
glutamic acid effects on the binding of radiolabeled kainic
Figure
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Figure 13. Effect of 1-glutamic acid on <3H)KA binding to 
forebrain synaptic membranes,
mouse
acid resulted in a competitive inhibition effect in the presence of 
Ca++ and Cl* ions. The mean concentration of 1-glutamate that inhibited 
the binding of the radioligand by 50% (IC5 0 ) was 8.4x10*® M for the 
total specific binding, and 1 .9x1 0 "^ M for the high affinity binding 
(Figure 13).
b. U-50488H- The effect of U-50488H on the KA binding to synaptic 
membranes is shown in Figure 14B. The mean IC5 0 for U-50488H was 
2.6x10*-* M for the total specific binding, and 4.9x10*^ M for the high 
affinity binding. U-50488H did not compete with the radioligand for 
binding on the rat forebrain synaptic membranes in a preparation 
without Ca++ (Figure 14A).
3. SCAT CHARD ANALYSIS - The Bmax and the Kj were determined from the
Scatchard analysis plot. The radioactivity measured in the samples 
containing cold KA was considered nonspecific binding (NSB) and was 
subtracted from all samples to obtain specific binding for each 
concentration. The maximum binding, or Bmax was measured in the absence 
of cold KA. Plots of the ratio of bound to free radioligand on the 
y-axis and the concentration of bound radioligand (nM) on the x-axis were 
constructed for each different ionic buffer (Figures 15 & 16). The 
resulting curves were linear, with a negative slope. The total number 
of receptor sites (Bmax) was obtained by linear regression. The 
constants of dissociation were obtained by taking the negative inverse 
of the slopes of the lines. Results are summarized in Tables 11, 12 and 
the statistical evaluations listed in Tables 14 and 15. The correlation
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Table 12. Kainic Acid Binding Parameters for Mouse Forebrain 
membranes in the Presence of U-50488H 10'^M. 
Scatchard Analysis.
Assay ^max
# (pM/mg protein)
I. Trls/Acetate buffer.
A. Ca++ 1.25 mM 
1.79 +/- 0-08
B. Ca++ 2.50 mM 
1.93 +/* 0.09
II. Tris/HCl buffer.
A. Ca++ 2.50 mM added
1.17 +/- 0.25 28.47 +/- 9 0.4822
Kd r
(nM)
26.35 +/- 2 0.9451
33.60 +/■ 5 0.3245
coefficients for kainic acid binding parameters by this analysis are 
summarized in Table 13.
a. INTER- AND INTRA- ASSAY COEFFICIENTS OF VARIATION FOR (3H)KA
RECEPTOR BINDING TO MOUSE FOREBRAIN SYNAPTIC MEMBRANES -Inter-assay and 
intra-assay percent coefficients of variation (CV) and the combined 
mean +/- SEM Bmax for each ionic condition are shown in (Tables 10 & 
12).
4. NON-LINEAR ANALYSIS - The Bmax and the K^ were determined by
non-linear analysis regression using a software Receptor Binding 
Program Package (Metzer & Weiner, 1984). The radioactivity measured in 
the samples containing cold KA was considered nonspecific binding (NSB) 
and was substracted from all samples to obtain specific binding for 
each concentration. The maximum binding or Bmax was measured in the 
absence of cold KA. Plots of the ratio of bound to free radioligand on 
the y-axis and the concentration of bound radioligand (nM) on the 
x-axis were constructed for each different ionic buffer. The resulting 
curves were linear in nature with an negative slope. By non-linear
regression to its intersecting point on the abscissa the total number
»
of receptor sites (Broax) was obtained. The constant of dissociation 
(K(j) was obtained by taking the negative inverse of the slopes of the 
lines.
Efforts to discriminate the low and high affinity sites
Table 13. Correlation Coefficients for Kainic Acid Binding
Parameters by Scatchard Analysis.
Comparison r obs
I. Ca++ free buffer.
®max vs• ^d 0.1922
II. Tris/Acetate buffer + Ca++ 2.50 mM.
®max vs. K(j 0.0149
III. Cl- and Ca++ 2.50 mM.
®max vs* Kd ND
Prob(r> r r1/Ho:rho-0 ^ a 
-0.8078 
-0.9997 
1.0000
a Probability of an r greater than the absolute value of the 
observed r given the null hypothesis of no correlation.
Table 14. Statistical Significance of Kainic Acid Binding
Parameters by Scatchard Analysis.
Comparison
XI vs. X2 P
Braax (pmol/mg protein)
Control vs. mM Ca++ added
Ca++ free vs. 1.25 0.0972
Ca++ free vs. 2.50 0.0650
Cl" added vs. 1.25 0.4166
Cl" added vs. 2.50 0.5032
Kd (nM)
Control vs. mM Ca++ added
Ca++ free vs. 1.25 0.7788
Ca++ free vs, 2.50 0 . 0 0 0 0 *
Cl" added vs. 1.25 0.3428
Cl" added vs. 2.50 0 . 0 1 1 2 *
* XI different from X2 (p<0.05).
Table 15. Statistical Significance of Kainic Acid Binding
Parameters by Scatchard Analysis in the Presence of U-50488H 
(10-5M).
Comparison
XI vs. X2 d
Bmax (pmol/mg protein) 
Control vs.
Ca4 4 free + Ca++ 1.25 mM 
0®++ free + Ca4 4  2.50 mM 
Cl- + Ca4* 2.50 2.50 mM
Kd (nM)
Control vs.
Ca4 4  free + Ca4 4  1.25 mM 
Ca4 4  free + Ca4 4  2.50 mM
Cl- + Ca4 4  2.50 mM
U-50488H
treated
10'5 
10"5
10-5
0.7770
0.4989
0.3036
U-50488H
treated
10* 5 M 
10*5 M
0.0272 * 
0.0000 *
0.4456
* XI different from X2 (p<0.05).
statistically were unsuccessful by this method. A very high standard 
error was necessary for the two site model to fit the data, and no 
reduction of the sum of squares residuals was obtained. The presence of 
two sites has been shown by London & Coyle (1979) and Simon, et al. 
(1976). The fact that we can not statistically demonstrate their 
presence does not invalidate their biological significance and our 
results are expresed as Bmax and corresponding to the horizontal 
portion of the curvilinear lines. These values of correspond to the 
low affinity component of the curves.
5. DISPLACEMENT OF (3H)KA FROM HIGH AND LOW AFFINITY BINDING SITES-
a. TOTAL SPECIFIC BINDING SITES- 1-Glutamate displaced the total 
specific binding of (3H)KA from the receptor sites of the mouse 
forebrain in a dose-dependent manner in the Ca^-free medium and in the 
presence of Ca"1-*- and Cl' ions (Figure 13) .
U-50488H did not significantly alter the specific binding of (3H)KA 
to the receptor sites in the mouse forebrain homogenate in the 
Ca++-free buffer. U-50488H did decrease the binding to the receptor 
sites in a dose-related manner in the presence of Ca++ ions (Figure 
14B) .
b. HIGH AFFINITY BINDING SITES- Advantage was taken of the fact that 
the radioligand dissociates slowly (Tjy2“ 90 min) from high affinity 
sites but nearly instantaneously from low affinity sites. The 
difference between total specific binding and high affinity binding 
represents the low affinity binding sites.
1-Glutamate displaced the (3H)KA binding to the high affinity 
binding sites in a dose-dependent manner in the Ca^-free medium, and
in the presence of Ca++ and Cl* ions (Figure 13). U-50488H did not 
significantly alter the binding of (^H)KA to the high affinity sites in 
the Ca^-free buffer. U-50488H did decrease the binding to the high 
affinity sites in a dose-dependent manner in the presence of Ca++ ions 
(Figure 14B).
c. STATISTICAL ANALYSIS- Student's t-test was used to statistically 
analyze the data. No significant change was observed in Bmax. The 
values in the presence of Ca++ were significantly increased at both 
concentrations of Ca’*"*" used. The results are shown in Table 15.
6 . RADIOLIGAND DEGRADATION - Degradation of the labeled (^H)KA Is not 
expected to exceed 1 % per month in the first six months after the 
initial analysis, but thereafter may accelerate. The radioligand was 
used as soon as it was shipped and stored at 2 C as advised by the 
manufacturer [r].
Ill 2-(3H)-DG uptake in various mouse brain regions
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A. BRAIN DISSECTION- The dissection of the septum, corpus striatum 
and hippocampus was done according to the diagram shown in Figure 17, 
following Montemurro & Dukelow (1972).
B, 2-(3H)-DG UPTAKE ASSAY -There were no significant differences 
between the saline control and the U-50488H treated group for the 
uptake of 2-deoxyglucose (2-DG) in the septum, corpus striatum, and 
hippocampus (unpaired t-test).
The data in Table 16 indicate that the i.v. administration of
kainic acid at 30 mg/Kg produced an increase of 2-DG uptake of 223, and 
209% in hippocampus, and septum respectively, when compared with saline 
controls (Footnotes a and . No significant changes were seen in the 
striatum.
U-50488H by itself or in the presence of KA did not significantly 
alter the uptake of 2-DG (Table 16) in the brain tissues studied nor 
did it block the increases induced by kainic acid.
Diazepam at 10 mg/Kg decreased 2-(3H)-DG uptake to 67% of the
saline control values in hippocampus. In the presence of 30 mg/Kg
kainic acid, diazepam at a dose of 10 mg/Kg decreased the 2-DG uptake 
to 40%, 37% and 37% of the kainic acid control values in mouse
hippocampus, corpus striatum and septum, respectively. Diazepam at 
doses of 3 and 1 mg/Kg did not produce these marked effects, Phenytoin 
(100 mg/Kg) decreased 2-(3H)-DG uptake to 72% and 74% of the saline 
values in hippocampus and corpus striatus, respectively.
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Figure 17. Drawing of mouse brain regions dissected for (^H)DG 
uptake. S- C. Striatum; H- Hippocampus; Se- Septum.
Table 16. Effects of U-50488H on 2-(^H)DG Uptake In Mouse Brain
PERCENT OF CONTROL (CPM+/-S.D.) a
HIPPOCAMPUS C. STRIATUM SEPTUM
GROUP
Saline
U-50488H
Diazepam
Phenytoin
DOSE
mg/Kg
1 0 0
1 0
1 0 0
30
1 0 0
117
67*
72*
144* 
PERCENT OF
1 0 0
81
89
74*
94
CONTROL CCPM+/-
1 0 0
87
70
87
95
■S.D.'k a
HIPPOCAMPUS C. STRIATUM SEPTUM
GROUP DOSE
mg/Kg
KA iv 30 1 0 0 1 0 0 1 0 0
U-50488H + 1 0 0 126 96 132
KA iv 30
U-50488H + 30 87 103 87
KA iv 30
Diazepam + 10 40* 37* 37*
KA iv 30
3 1 1 1 96 78
1 85 72* 83
Phenytoin + 30 73* 77* 63
KA iv 30
10 107 89 75
* p<0.05 , Student's t-test. df-15
a Saline control CPM/mg of tissue(+/-S.D.): 
HIPPOCAMPUS C. STRIATUM SEPTUM
183+/-24 263 +/- 54 187 +/- 22
“ KA Control CPM/mg of tissue(+/-S.D.):
HIPPOCAMPUS C. STRIATUM SEPTUM
408+/-132 252 +/- 392 +/- 98
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A 30 mg/Kg dose significantly blocked the increase induced by kainic 
acid (Table 16).
IV IMAGE ANALYSIS QUANTITATION OF KAINIC ACID LESIONS IN MOUSE
HIPPOCAMPUS AND THE PROTECTIVE EFFECTS OF THE ADMINISTRATION OF 
U-50488H.
A. HISTOPATHOLOGY
1. DESCRIPTION OF KA LESIONS - Histopathological changes with KA were 
restricted to the neurons and associated neuropil of the granular layer 
in the CA3 region of the hippocampus. Extensive degeneration and
necrosis of neurons resulted in dark, shrunken cell bodies and
vacuolization of the neuropil associated with pyknotic neurons. The 
site of injection was confirmed histologycally, a typical injection 
site is shown in Figure 18.
2. PHOTOGRAPHIC DISPLAY- Typical KA lesions in the CA3 region of the 
hippocampus are shown in Figure 4 at the five levels used for
quantitation in this study.
The effect of U-50488H administration on kainic acid-induced 
lesions is shown in Figure 5 and Table 17. The lesions were decreased 
in size after treatment with U-50488H (100 mg/Kg) . Less vacuolization and 
degeneration of neurons was present in the CA3 region of the hippocampus
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Figure 18. Site of KA intracerebroventricular injection. H and E 
stain. 20X.
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after treatment, but patches of necrotic changes were still observed.
B. IMAGE ANALYSIS
1. ACQUISITION AND PROCESSING OF IMAGES - Images of a 200x200 pixel 
area from the CA3 region of the hippocampus of every animal in every 
group were acquired using a Nikon Magiscan Image Analysis system 
incorporating a Dage black and white video camera mounted on a Nikon 
Fluophot microscope fitted with a 20x objective lens. All operations of 
the image processor were controlled by the computer. The computer 
digitized the signal to 6 -byte resolution and stored it for image 
processing. A representative KA treated group is shown in Figure 19.
2. QUANTITATION - Total area of vacuolization (mm^) was measured for 
each animal on both sides of the brain. The data are shown in Table 
17. In the injection side, the area of vacuolization (mm^) was 1.45 +/- 
0.90 and 0.22 +/- 0.43 for KA and KA+ U-50488H respectively. The 
contralateral side area of vacuolization (mm^) was 0.37 +/* 0.63 and 
0.01 +/- 0.02 for KA and combined treatment respectively.
<
3. STATISTICAL ANALYSIS - The data were analyzed by one-way analysis 
of variance by pairwise comparison of treatment means using Fisher's 
Least Significant Difference (LSD) (Table 18).
Table 17. Effects of U-50488H on the Area of KA Induced 
Vacuolization in the CA3 Region of the House 
Hippocampus.
Total Area of Vacuolization
TREATMENT M SIDE la SIDE 2b
Saline 8 0.05 +/- 0.06 0.01 +/' 0.03
KA 0.08 ug lev 5 1.45 +/- 0.90 * 0.37 +/- 0.63
U-50488H lOOmg/Kg 5 o.oo +/- o.oo 0.00 +/- 0.00
KA 0.08 ug icv +
U-50488H 100 mg/Kg 5 0.22 +/* 0.43 ** 0.01 +/- 0.02**
a Injection side.
13 Contralateral side.
* statistically significant when compared with saline control (p<0.05). 
** statistically significant when compared with KA control (p<0.05).
Figure 19. Digitized image of mouse hippocampus lesion with KA.
For the LSD analysis, those comparisons which were applied to test the 
null hypotheses that all of the populations are identical against the
alternative that some of the populations tend to furnish greater
observed values than other populations. This test also confirmed the 
significant difference between the KA treated group and the combined 
treatment with U-50488H + KA. For the Kruskal-Wallis test (chi-square 
approximation) a PROB > CHISQ - 0.0002 was used in the contralateral 
side and a PROB > CHISQ — 0.0001 in the injection side. The
significance of the test for all comparisons is shown in Tables 19 & 20.
Table 18. Analysis for Variable Mean Area of Vacuolization Induced by 
KA in the CA3 Region of the Mouse Hippocampus.
Wilcoxon Scores (Rank Suras)
Side 2 (Contralateral Side}
GROUP N SUM OF EXPECTED STD DEV MEAN
SCORES UNDER HO UNDER HO SCORE
Saline 6 122.50 117.00 24.35 20.42
KA 7 212.00 136.50 25.89 30.29
U-50488H 6 61.00 117.00 24.35 10.17
KA +
U-50488H 5 98.00 117.00 24.35 16.33
Kruskal-Wallis test ( chi-square approximation) 
CHISQ- 24.62 df - 5 PROB > CHISQ- 0.0002
Side 1 (Infection Side}
GROUP N SUM OF EXPECTED STD DEV MEAN
Saline
SCORES! UNDER HO UNDER HO SCORE
6 114.00 117.00 24.86 19.00
KA 7 245.00 136.50 26.43 35.00
U-50488H 6 61.50 117.00 24.86 10.25
KA +
U-50488H 5 123.50 117.00 24.86 20.58
Kruskal-Wallis test ( chi-square approximation) 
CHISQ- 30.37 df - 5 PROB > CHISQ- 0.0001
Table 19. Analysis for Variable Mean Area of Vacuolization 
Induced by KA in the CA3 Region of the Mouse 
Hippocampus.
Kruskal-Wallis Test ( Chi-Square Approximation) 
Side 1 (Contralateral Side)
Treatment Comparisona Lc uieiiL uuiiiu i uii
N DF CHISQ PROB > CHISQ
Saline vs. KA 7 1 3.45 0.0633
U-50488H 6 1 5.40 0.0201
KA +
U- 50488H 6 
Side 2 (Infection Side)
1 0.33 0.5683
Treatment ComDarison
N DF CHISQ PROB > CHISQ
Saline vs KA 7 1 9.00 0.0027
U-50488H 6 1 6.66 0.0099
KA +
U-50488H 
Side 1 (Contralateral
6
Side)
1 0.41 0.5218
Treatment Comparison
N DF CHISQ PROB > CHISQ
KA vs. Saline 1 1 3.45 0.0633
U-50488H 6 1 9.25 0.0023
KA +
U-50488H 6 
Side 2 (Infection Side)
1 4.64 0,0312
Treatment ComDarison
N DF CHISQ PROB > CHISQ
KA vs. Saline 6 1 9.00 0.0027
U-50488H 6 1 9.10 0.0026
KA +
U-50488H 6 1 9.00 0.0027
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Table 20. Analysis for Variable Mean Area of Vacuolization Induced by KA 
in the CA3 Region of the Mouse Hippocampus.
WILCOXON 2-SAMPLE TEST (NORMAL APPROXIMATIONS 
Side 1 (Contralateral Side I 
Treatment Comparison APPROX
N S Z PROB >[Z] SIGNIFIC
Saline vs. KA 7 29.00 1.7857 0.0741 0.0994
U-50488H 6 53.00 2,2415 0.0250 0.0466
KA +
U-50488H 6 42.50 0.4890 0.6248 0.6344
Side 2 (Inlection Side! 
Treatment Comparison
N S Z PROB >[Z] APPROX
SIGNIFIC
Saline vs. KA 7 21.00 2.9286 0.0034 0.0126
U-50488H 6 55.00 2.4995 0.0124 0.0295
KA +
U-50488H 6 35.00 
Side 1 (Contralateral Side’J
0.5604 0.5752 0.5864
Treatment Comparison
N S Z PROB >[Z] APPROX
SIGNIFIC
KA vs. Saline 6 29.00 1.7857 0.0741 0.0994
U-50488H 6 21.00 3.9696 0.0030 0.0117
KA +
U-50488H 6 27.00 2.0829 0.0373 0.0593
Side 2 (Infection Side1) 
Treatment Comparison
N S Z PROB >[Z] APPROX
SIGNIFIC
KA vs. Saline 6 21.00 2.9286 0.0034 0.0126
U-50488H 6 21.00 2.9448 0.0032 0.0123
KA +
U-50488H 6 21.00 2.9286 0.0034 0.0126
DISCUSSION
I 45Ca++ UPTAKE BY RAT SYNAPTOSOMES.
Synaptosomal preparations are an extremely valuable In vitro model 
to study ion fluxes; results of fundamental Importance to the 
understanding of the kinetics of uptake have been published
with this preparation (Blaustein, 1975; McGraw, et al. , 1982; Adam-Vizi 
& Ligeti, 1986; Carvalho, et al. , 1985). These results have been very 
informative in understanding the contribution of the voltage-dependent 
and independent Ca++ channels, but it must be kept in mind that 
synaptosomal preparations represent nerve terminals from an enormous 
variety of neuronal groups and that these neuronal types may have 
differing calcium regulating processes (McBurney & Neering, 1987). The 
method of preparation of the synaptosomes introduces great variability 
in these types of experiments. The membrane can be made very leaky 
depending on the material used for the gradient.
Calcium influx through voltage dependant or independent calcium 
channels is of great importance in the regulation of nerve function and 
may lead to important secondary changes in nerve excitability and to 
neuronal degeneration (Miller, 1987; McBurney & Neering, 1987). The 
calcium uptake due to elevated K+ is related to membrane depolarization 
and other mechanisms. At the resting membrane potential in dialyzed 
axons, it has been found that 70% of the calcium influx was sensitive 
to tetrodotoxin, 20% was Na+/Ca++ exchange, and the remaining 10% was 
leakage in dialyzed axons (Requena, 1983), The preincubation time and 
medium are crucial in determining the final ionic content of
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synaptosomes. The activity of the Na+-Ca++ exchange mechanism when the 
external medium is made high in K+ (K+ substituted for Na+) is 
responsible for entrance of Ca++ (Carvalho, et al. , 1985; McGraw, et 
al.. 1982). Preincubation in a K+-rich medium results in inhibition of 
the K+-depolarized uptake since neither a normal resting membrane 
potential nor a Na+ gradient exists (Carvalho, £t al., 1985; McGraw, et 
al., 1982).
There is disagreement on the terminology used to name the two 
phases of the calcium accumulation process in synaptosomes. "Fast 
phase" was defined by Blaustein, (1975); and McGraw, et al., (1982) as 
a brief period of rapid uptake which is complete within 1-3 sec, while 
uptake values up to 30 sec were taken to represent the fast phase by 
Gripenberg, et al,.(1980), We adopted the later definition of fast 
phase and utilized an 8 sec incubation time unless stated differently.
We found that proveratrine, a Na+ channel agonist, enhanced Ca"1"*" 
uptake when added to synaptosomes in the incubation medium, both at 
rest and under depolarizing conditions* Furthermore, verapamil and 
nifendipine blocked the C^a"*""*" uptake in depolarized synaptosomes. 
These results are consistent with other published data (Richards, et 
al. , 1984). Thus the synaptosomes utilized in these studies apparently 
had functional K+, Na+ and Ca++ channels, and their membranes could be 
polarized and depolarized by the flux of these ions through their 
respective channels.
The regulation of intracellular calcium is a very complex system 
not yet fully understood. The participation of pathways with different 
properties is not straighforward and is presently the subject of 
intense investigation.
Our data demonstrated the existence of active voltage-sensitive 
Ca4"4" channels in the synaptosomal preparation. In the presence of 
external sodium, calcium blockers had no effect on the accumulation of 
-^’Ca++ in controls, but were able to block a portion of the 
K+-stimulated uptake.
The Ca4"4" channel agonist, BAY K 8644 did not enhance Ca4"4" uptake in 
this preparation either in the presence or absence of depolarizing 
concentrations of K+ . The reason for this is not clear but it suggests 
that the site of the convulsant action of this compound may not be the 
nerve terminal Ca++ channel (Von Voigtlander, at al., 1987) .
In conclusion, a substantial component of the ^ C a ++ uptake is 
blocked by two major classes of organic Ca4"4" blockers, dihydropyridines 
(nifedipine) and phenylalkylamines (verapamil), and by a third group of 
opiate related compounds: a kappa agonist, U-50488H, and naloxone.
The results showed that U-50488H blocks the influx of ^5Ca++ in K+ 
depolarized synaptosomes. This effect was seen only in the early phase 
of the biphasic time-course of K+-stimulated Ca4"4" influx. The early or 
fast phase is voltage regulated, inactivated by pre-depolarization and 
low concentrations of La4"4", and excess K+ is necessary to open the 
calcium channels in the presence of a high concentration of Mg++ 
(Nachshen & Blaustein, 1980). This early phase has been associated with 
neurotransmitter release (Blaustein & Goldring, 1975; McGraw, et al. , 
1982) . The fast phase of Ca4"4" uptake is inactivated by prior 
depolarization of the synaptosomes. However, pre-depolarization has no 
effect on the slow phase of Ca++ uptake (McGraw, et al. , 1982). Our 
results are consistent with other studies (McGraw, et al. , 1982) and
investigations in electrophysiological systems (Lee & Tsien, 1983) 
which demonstrated Ca-*-* channel inactivation by depolarization.
The fact that a voltage dependent mechanism is implicated in the 
blockade of ^ C a ++ uptake by U-50488H is further supported by the 
decrease of the same magnitude observed with verapamil and nifedipine 
for the early phase uptake under depolarizing conditions.
The relatioship between Ca"*-*" channel blockade and mu opioid 
receptor mediated mechanisms is unclear. The possibility that opioids 
inhibit neurotransmitter release by disturbing voltage-dependent 
presynaptic Ca'*"f uptake during polarization through opioid receptors 
was suggested by Kamikubo, fit al., (1983). Our results failed to show 
this inhibitory activity of morphine. No effect on K+-stimulated Ca"*"*" 
uptake during the fast or slow phase of uptake at rest was observed 
with the indicated preincubation times and uptake measurents used in 
this procedure.
U-50488H has been shown to be unique in its affinity and 
selectivity for the kappa receptor (Lahti, et al. , 1981; Von
Voigtlander, et al., 1983; Tang, 1982; Tang & Code, 1983; Mickelson & 
Lahti, 1985. The benzomorphans, dynorphin A (an endogenous peptide), 
U-50488H, and its analogs have high affinity for the kappa site. It has 
been demonstrated that KA-induced seizures alter hippocampal levels of 
dynorphin as well as Met^-enkephalin-like (ME-LI) immunoreactivity 
(Kanamatsu, et al. , 1986). A visible decrease in dynorphin A (1-8) *-n 
mossy fiber axons within 6 hours after KA was followed by a substantial 
increase at 48 hours.
The role of these opioid peptides in KA-induced neurotoxicity does 
not appear to be primary, but they may still play an important role in
modulating neuronal excitability in the hippocampus. It is possible 
that KA Induces a release of enkephalin from the projections of the 
enthorhinal cortex and dentate granule cells. This release enhances 
KA-induced neuronal excitability and also induces release of dynorphin, 
which may act in a compensatory manner to reduce hippocampal 
excitability (Kanamatsu, et al. , 1986). It may be possible that the 
cytoprotective effect of U-50488H is mediated by stimulating this 
compensatory mechanism to reduce excitability.
It has been shown that naloxone pretreatment attenuates the 
convulsions and cell loss induced by high doses of KA, and morphine 
potentiates seizures and cell loss after intermediate doses of KA 
(Fuller & Olney, 1979).
The portion of the Na+-Ca++ exchange transport system that is 
altered by U-50488H is demonstrated by the blockade of K+-stimulated 
calcium accumulation in the absence of Na+ ions. The effects of choline 
substitution for external Na+ have been studied extensively (Blaustein 
& Oborn, 1975; Blaustein & Hodgkin, 1969; Blaustein, 1984). This 
particular type of Ca++ channel, the Na+-Ca++ carrier, exchanges one 
Ca++ for three or more Na+ ions counter transported. Since net charge 
is moved by the carrier, the transport can be voltage regulated 
(Blaustein, et al. , 1974). The energy Is provided by the
electrochemical gradient across the membrane. The exchange appears to 
be symmetric In that Ca++ can move in both directions, depending upon 
the prevailing Na+ gradient. When the Na+ gradient is reduced (e.g. by 
inhibiting Na+-K+ pump activity and increasing the intracellular Na+ 
concentration or by depolarizing the cells), net Ca++ influx takes 
place. In brief, Ca++ Influx is increased when external Na+ is reduced
and/or Internal Na+ Is Increased. Conversely, Ca++ efflux from ^ C a ++ 
loaded synaptosomes is reduced when external Na+ is lowered (McGraw, 
et al.. 1982). In the present study, K+-stimulated calcium uptake was 
not apparent in the absence of Na+ . Results by Turner & Goldin (1985) 
showed increased calcium influx during the first 4 sec. U-50488H did 
not alter the fast phase component of the calcium uptake by depolarized 
synaptosomes. In a Na+-free and K+-rich medium, where neither a 
membrane potential nor a sodium gradient probably existed in the 
synaptosomes (Carvalho, et al. , 1985), no activity could be observed 
during the early phase with U-50488H. The contribution to the slow 
^ C a ++ uptake which is Na+-dependent and perhaps altered by U-50488H 
was not studied.
Demonstration of a component associated with the decrease of ^ C a ++ 
uptake in depolarized synaptosomes in the presence of U-50488H is not 
easy at this point. Previously mentioned differences in preparation of 
synaptosomes, incubation time and medium make interpretation of results 
difficult. However, the best candidate for an activity of U-50488H will 
be a mechanism related to long term regulation of neuronal activity, 
such as the regulation of resting potentials, since the early phase of 
Ca++ uptake is mostly related to secretion of neurotransmiters and our 
measurements were taken at the end of the early uptake curve. Other 
mechanisms to explore will be receptor operated channels controlled by 
calcium binding proteins such as calmodulin, parvalbumin, calbindin and 
PEP-19. Calbindin appears to be located in hippocampal CAl pyramidal 
and dentate granule cells, and calmodulin in the cell bodies and 
dendrites of most neurons in the CNS (Meldrum, 1984; McBurney & 
Neering, 1987).
The selective vulnerability of hippocampal neurons during status 
epilepticus is associated with Ca++ movement into the neurons and is 
attributable to membrane properties that give rise to burst firing and 
an excessive, sustained entry of calcium (Meldrum, 1981). The events 
that take place after the entry of calcium may in turn influence other 
processes such as permeability, activation of peptidases and proteases 
and exposure of glutamate receptors in the membranes. This will make 
the neurons more susceptible to excitatory inputs and more likely to 
show hyperexcitability states (Baudry, e£ al. , 1983). Demonstration of 
changes in calcium uptake by synaptosomes in the presence of 
excitatory amino acids and U-50488H will support the theory of the 
involvement of excitatory amino acids in the pathology of epilepsy and 
the cerebroprotective effects of drugs that will act on this mechanism. 
No significant differences were observed in the mean values for -^’Ca++ 
uptake by synaptosomes at rest or under depolarizing conditions when 
measured in the presence of NMDA or kainic acid. However, there was a 
significant decrease when glutamate was added to the system at rest 
and in depolarizing buffer. The presence or absence of Mg++ did not 
influence this decrease of -^*Ca++ uptake by the synaptosomes.
The contribution of the mitochondria as a buffering system for 
intracellular calcium may be an interesting process to investigate in 
association with the blocking activity of U-50488H. This system has an 
extremely high capacity for Ca-1-1" and stores it in an inert form as 
Ca(P0 4 )2 . This energy-linked process can be supported by either 
electron transport or by the hydrolysis of ATP. It successfully buffers 
the massive calcium influx into hippocampal neurons associated with 
seizure activity (Griffiths, et al. , 1984). It may be associated with
che terminal cisternae of the ER as calcium sequestering organelles, 
providing a direct pathway for the transport of Ca"1"1" from within the 
neuron to the extracellular space (McBurney & Neering, 1987), More 
studies will be necessary to reveal the exact site of action of 
U-50488H in the complex scheme of calcium-dependent processes 
affecting neuronal activity.
II (3H)KA BINDING ASSAY
The purpose of using this binding assay was to evaluate the effect 
of U-50488H as a displacer of (3H)KA binding under different ionic 
conditions. The role of excitatory amino acids in regulating neuronal 
excitability is not well defined. Evidence is accumulating suggesting 
that a mechanism involving elevation of intracellular Ca++ Is important 
in the regulation of synaptic plasticity (Morris, et al., 1986) and In 
mediating some pathophysiological effects of amino acid excitotoxicity 
(Choi, 1985). The anticonvulsant action of NMDA receptor antagonists 
highlights the role of NMDA receptors in regulating excitability 
(Meldrum, 1985). Even though 1-glutamate and related acidic amino acids 
are firmly established as major excitatory synaptic substances in 
vertebrate CNS, the characterization of these receptors is still at an 
early stage. Selective antagonists are not available and KA and 
quisqualate are not as specific as originally thought. These facts 
obscure the determination of the precise mechanism of action of these 
substances and their analogues and antagonists at the excitatory 
synapses.
The role of NMDA and non-NMDA receptors in the convulsant or 
anticonvulsant effects related to epilepsy is not known. However, it is 
believed that more than one type of receptor for excitatory amino 
acids is engaged in seizures, irrespective of the receptors 
preferentially activated in the initiation of the convulsions.
In order to draw meaningful conclusions in terms of receptors 
involved in the physiological events underlying seizures, the 
availability of individual antagonists is essential. U-50488H 
antagonizes seizures induced by both KA and NMDA (Von Voigtlander, e£ 
a],. , 1986). This observation is of great interest in view of the
suggestion that the voltage-dependent behavior of conductance activated 
by NMDA receptors may modulate responses induced by non-NMDA receptors 
(Majer & Westbrook, 1984), U-50488H anticonvulsant effects suggest that 
the same ionic mechanisms underlying the seizures are being protected. 
The (^H)KA binding assay may be used as a tool for the development of 
anticonvulsant drugs. Compounds which displace the binding of 
radiolabeled excitatory amino acids from their receptors might be 
excitatory amino acid antagonists and anticonvulsants.
In the absence of highly selective antagonists, the antagonism of 
KA induced seizures by U-50488H provides us with a new chemical 
structure which might prove to be a displacer of KA binding. (^H)KA was 
used in this study due to the previously described hypothesis of 
kainate and quisqualate receptors as primary mediators of rapid 
excitatory signals at acidic amino acid synapses (Fagg, 1986).
Assay conditions were similar to those described by London and 
Coyle (1979). Endogenous glutamate was released by an incubation of 30
min at 37 C and subsequent washing and centrifugation of the synaptic 
membranes.
The results of the present study showed that only one population of 
receptors was detected by this ligand binding technique when assayed in 
a Ca^-free buffer. Other studies have shown the presence of two sites 
(London & Coyle, 1979; Simon, e£ al., 1976; Unnerstall & Wamsley, 1983; 
Monaghan & Cotman, 1982; Tremblay, et al., 1985; Honore, et al., 1986) 
in the rat brain. The rationale for using mice was to be able to 
correlate binding with the physiological and morphological studies. 
However in the mouse brain study in the mouse brain, performed in the 
presence of Cl" and Ca++ ions the linear model for one site was 
automatically rejected by the statistical package on the basis of the F 
test and the Akaike information criteria (ACI).
Assay precision was high when determinations were made in the Ca++- 
free system, whereas precision in the presence of (Ca++ 2.5 mM) was not 
as good. This lack of precision in the (^H)KA binding assay could be 
attributed to the washing method which might have introduced 
significant error by disrupting the binding sites.
There are two findings in this study that support the hypothesis 
that U-50488H is involved in a Ca++ related anticonvulsant mechanism. 
First is the finding that the affinity (K^) of the KA receptors was 
decreased in the presence of Ca++ (2.5 raM). Second is the finding of 
the decrease of the population of receptors (Bmax) in the presence of 
U-50488H, Ca++, and Cl*. Previous experiments by Rothman (1985)
suggested that the pathophysiology of amino acid neurotoxicity may be 
due to the passive distribution of Cl* ions under depolarizing 
conditions. An increase in intracellular Cl* concentration cannot be
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compensated by outward anion flux, because the bulk of intracellular 
anions are impermeant. Therefore, more cations (i.e.Ca"*-*") are drawn 
into the cell, which increases intracellular osmolarity and water 
enters the cell. Lysis follows after excessive tension in the cellular 
membrane.
Calcium has been associated with the phenomena responsible for 
neuronal lysis during hypoxic injury, seizure activity and spinal cord 
contusion (Siesjo, 1981). Release of glutamate is enhanced by Cl" and 
Ca++ (Nadler, et al. , 1985) and may be responsible for the neuronal 
damage observed under these conditions. Kainate produces edema, 
astrocytosis and reduction of protein content. The accumulation of Ca++ 
undergoes dramatic changes after kainate. This is possibly associated 
with the binding of this cation to macromolecules or molecular 
aggregates formed or released by the disintegrating neural elements 
(Korf & Posterna, 1984). The mechanism underlying the protective effect 
of U-50488H is not clear, though a marked reversal of the affinity of 
the kainate receptors in the presence of Ca++ and Cl" ions is evident 
in the presence of this compound.
Ill (3H)-DG UPTAKE IN VARIOUS MOUSE BRAIN REGIONS.
Radiolabeled 2-deoxyglucose has been widely used to measure 
regional metabolic rates in the brains of laboratory animals (Sokoloff, 
et al. , 1977). The theoretical basis of this technique rests on the
facts that neurons use glucose as their main source of energy, and 
hyperactivity states lead to an increase of energy expense. The 
radiolabeled deoxyglucose is administered intravenously as a pulse,
which is then taken up by the neuron and phosphorylated as if it were 
normal glucose, but is not further metabolized. The labeled 2-DG is 
trapped inside the cell In concentrations proportional to the 
integrated uptake of glucose. Liquid scintillation counting of the 
solubilized areas of the brain provide a measure of local activity. 
This type of experiment was relatively easy to prepare and a rapid 
determination of a trend could be obtained indicating an effect of 
U-50488H on neuronal metabolism. A potential disadvantage that was 
observed was that the standard error was large, and attempts to 
correlate the data may be obscured by the high variation between mice. 
(^H)DG was used in this study to follow the distribution of labeled 
material following pretreatment with KA and U-50488H. The conditions 
for assaying changes in mice were similar to those reported by Von 
Voigtlander, et al. , (1983). This semiquantitative method was used to 
evaluate the metabolic alterations in structures which are known to be 
associated with epileptiform activity (hippocampus, corpus striatum and 
septum).
Other studies using ^C-DG have shown the effects of KA after 
systemic administration; the brain area affected primarily was the 
limbic system (Ben-Ari, et al. , 1981). The present results similarly
t
demonstrate enhanced glucose utilization after i.c.v. KA.
The role of excitatory amino acids in the brain damage observed 
after seizures is not fully understood. Metabolic and electrographic 
changes have provided evidence that the hippocampus, the amygdala and 
other limbic structures occupy a central position in this syndrome. 
Autoradiographic deoxyglucose maps revealed an increase in glucose 
consumption exclusively in the hippocampal formation and lateral septum
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(Ben-Ari, et al., 1981) in less than 1 hr after systemic administration 
of KA. At longer delays, structures receiving hippocampal projections 
are progressively involved, showing a remarkable correlation between 
electrographic changes and the rise of metabolism. Furthermore, the 
signs of degeneration observed were almost exclusively located in 
structures in which there had been a rise in metabolism (Ben-Ari, ££ 
al., 1981).
The results of this study showed that no significant changes were 
produced in the uptake of 2DG in the hippocampus, corpus striatum or 
septum of mice with U-50488H, nor did U-50488H did block the effects 
of KA detectable with this procedure.
In contrast, standard anticonvulsants such as diazepam and 
phenytoin showed a marked inhibition of the increased glucose 
metabolism induced by KA in the limbic system. Metabolism was also 
decreased when the drugs were administered by themselves. Thus, the 
anticonvulsant effect of these compounds may be independent of the 
excitatory amino acid mechanism. It is suggested that the mechanism of 
action of U-50488H may be related to other aspects of the seizure 
syndrome but not to metabolic changes. The similarities between the 
effects of KA and of (D-Ala^, D-Leu^) enkephalin (DADL), an opioid 
peptide (Aitke, 1985; Routtenberg, et al. , 1984), are suggestive of a 
mechanism involving release of an endogenous opioid from mossy fibers 
as a normal mechanism for enhancement of CA3 pyramidal cell 
excitability. This endogenous opioid could be dynorphin. U-50488H's 
effect as an anticonvulsant may be mediated through such an 
opioid-related mechanisms.
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IV EFFECTS OF U-50488H ON KAINIC ACID INDUCED LESIONS IN THE MOUSE 
HIPPOCAMPUS. A MORPHOMETRIC STUDY BY IMAGE ANALYSIS
The excitatatory amino acids have been suggested to be the common 
pathogenic factors in epilepsy, hypoglycemia and cerebral ischemia. 
Differences in the distribution of damage have been explained by 
differences in the site of excitatory amino acid release, type of 
receptor activated, or secondary intracellular reactions such as 
acidosis (Siesjo & Wieloch, 1986).
The purpose of this study was to obtain a quantitative measurement 
of the effects of U-50488H pretreatment on the area of vacuolization 
induced by KA in the hippocampus. The image analysis method permits the 
assessment of local neuronal damage in brain regions by measuring the 
area of vacuolization. In this study, attention was restricted to a 
region of the hippocampus, the CA3 area, selected on the basis of the 
presence of lesions after i.c.v. KA administration.
An is vivo study of the anticonvulsant properties of U-50488H was 
undertaken using a small animal model, where recovery was allowed 
following the establisment of KA-induced lesions. We observed the 
density and distribution of neuronal damage in the hippocampus in 
control and U-50488H pretreated mice after a 4 day recovery. The design 
of this study overcame the shortcomings limiting the traditinal 
subjective interpretation of lesions by light microscopy. It provided 
us with a procedure of high resolution to study the cytoprotective 
activity specifically related to the anticonvulsant activity of
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U-50488H. The neuronal damage quantified by measurement of the area of 
vacuolization was used as a marker for neuronal protection.
The seizure pattern produced by i.c.v. KA was similar to that 
described earlier in rats (Ben-Ari, 1981; Nitecka, £t fil. , 1984). These 
and other observations suggest that this is a good model of temporal 
lobe epilepsy. The determination of long term sequelae in this animal 
model, notably in respect to the prevention of the pathological 
processes, may contribute to the understanding of the anticonvulsant 
and cytoprotective effects of U-50488H.
Convulsive seizures occurred twenty minutes after i.c.v. injections 
of KA, but not all mice treated with KA showed overt seizures. The 
animals observed for 1 hr after the neurotoxin injection displayed 
general agitation, forepaw tremors, salivation, jumping and tonic 
convulsions. Mice pretreated subcutaneously with 100 mg/Kg U-50488H did 
not show any of these abnormal behaviors. Survival was 100% for both 
groups at the end of the 4 days.
Prominent histopathological alterations were observed in the CA3 
region of the hippocampal formation of the KA treated group. The 
alterations included shrinkage of tissue, progressive degeneration of 
neurons, necrosis associated with cell loss and proliferation of glial 
elements. Pathological alterations of the CA1 subfield were rare and 
restricted to a very small area when found. No damage was observed in 
other areas of the brain under general examination of the tissues. The 
image analysis was restricted exclusively to the CA3 area of the 
hippocampus.
The histopathological changes observed in the animals pretreated 
with U-50488H before neurotoxin administration were qualitatively
106
similar to those observed in the KA treated controls. However, the 
cellular loss was markedly reduced and the area of vacuolization found 
was significantly decreased.
The assumption in current efforts to localize the histopathological 
changes in kainic acid seizure-brain damage syndrome is that the 
neuronal loss and the development of gliotic scars, especially in 
limbic structures following KA administration, is reminiscent of that 
seen inhuman temporal lobe epilepsy (Ben-Ari, 1985), Investigations on 
KA effects have examined whether the reported brain lesions following 
intracerebroventricular KA were secondary to the seizures induced by 
this neurotoxin or a direct action of this convulsant agent. 
Fretreatment with diazepam reduced hippocampal damage without reducing 
the toxic effects of KA at the site of the injection. These results 
suggest that the distant brain lesions may be selective and secondary 
to the sustained epileptiform activity (Ben-Ari, et al. , 1979). The
severe cytotoxic brain edema reflected by the massive swelling of 
perlneuronal and perivascular astroglia may result in disturbance of 
the local microcirculation and may play a very important role in the 
pathogenesis of cellular damage. This can be regarded as a local 
non-selective damaging process which may have an important role in the 
development of neuropathological alterations. The selective 
seizure-related damage is accompanied by calcium accumulation or zinc 
release (Sztriha, et al. , 1986). The selective effects of KA are
influenced by anticonvulsant drugs such as diazepam while the 
non-selective effect is prevented by mannitol (Lassmann, e£ al., 1984).
The role of different types of edema in cell death associated with 
epilepsy is not clearly understood. Vasogenic edema may contribute to 
cell damage observed in thalamus but not to that one observed in the 
hippocampus. Dexamethasone has been shown to protect against vasogenic 
brain edema in the thalamus but it does not influence the cytotoxic 
damage observed in the hippocampus. The role of newly synthetized 
protein(s) with antiphospholipase A2 activity are suggested in the 
anti-edema action of dexamethasone (Ruth, 1984; Sztriha et al., 1986).
The results of this study suggest that U-50488H has a protective 
effect due to its actions on two different kinds of mechanisms. The 
first is the anticonvulsant component of the effect, which may be 
related to its ability to antagonize seizures elicited with KA, other 
excitatory amino acids and BAY K 4688. This effect is probably related 
to calcium but may be also related to the ability of U-50488H to 
antagonize the discharges produced in the CA3 region of the hippocampus 
and the recurrent activation of the araygdalohippocampal axis. A high 
density of KA binding sites has been found in the stratum lucidum of 
the CA3 region of the hippocamus, which has been shown to be the most 
vulnerable structure to the excitatory and cytotoxic effects of KA 
(Berger & Ben-Ari, 1983). The excitatory amino acids are linked to 
mixed ionic mechanisms involving Cl', Ca++, Na+ , and K+ (Mayer & 
Westbrook, 1985) but the precise nature of the permeability changes 
caused by these compounds remains unclear. The second is the anti-edema 
effects of U-50488H, which have been shown to prevent increases in 
water, Na+ and K+ content (Silvia, et al., 1987); these effects seem to
be related to a reduction of circulating ADH as well as to a direct 
effect on the kidney (Slizgi & Ludens, 1982).
However, the importance of this antiedema property to the present 
observations must be questioned as U-54494A, which shares the 
anticonvulsant mechanism of U-50488H (Von Voigtlander, al. , 1987^) 
and blocks KA lesions (Camacho Ochoa, et §0i-• 1987), does not have
water diuretic or antiedema properties (Ludens & Tang personal 
communications). More experimentation will be necessary to completely 
elucidate the cerebroprotective effects of U-50488H.
CONCLUSIONS
Effects of U-50488H on -^’Ca+'*' uptake by rat synaptosomes, (^H)KA 
binding to mouse synaptic membranes, and antagonism of KA-induced 
lesions in the CA3 region of the mouse hippocampus support our 
hypothesis that the cerebroprotective effect of this compound is 
associated with a calcium-related mechanism underlying seizures.
The ^ C a ++ uptake data were obtained from classical synaptosomal 
preparations purified in Ficoll gradients. The values observed 
indicated that U-50488H decreased the increased Ca++ uptake elicited by 
depolarizing K.+ concentrations and that this effect was related to 
voltage regulated channels.
The preparations used were physiologically responsive to different 
Ions of importance in control of permeability of the neuronal membrane. 
The variability of these experiments may be due to the size, brain 
region origin and viability of the synaptosomes isolated with Ficoll. 
However, the reduction in calcium uptake was evident in the presence of 
U-50488H.
Binding of (^H)KA to receptor sites on mouse forebrain synaptic 
membranes was decreased by U-50488H in the presence of calcium and 
chloride ions. The binding parameters of (^H)KA were determined from 
Scatchard plots in standard mouse washed synaptic membranes. The 
results indicated that in the presence of U-50488H the density of KA 
receptor binding sites decreased, while the K^ values obtained 
indicated a shift towards higher affinity receptor sites. These 
changes suggest alterations in the shape of receptor proteins, which 
may be due to calcium interactions.
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No significant differences were observed in mean values for (^H)DG 
uptake in the presence of U-50488H when compared to kainic acid 
controls. These findings indicated that the cerebroprotective effects 
of this compound are not glucose metabolism related. Other metabolic 
probes will be valuable to facilitate the understanding of U-50488H 
effects on the hyperexcitable neuron's metabolic pathways. The 
significant increases of (^H)DG uptake observed with kainic acid in 
brain areas related to generation of seizures emphasizes the role of 
excitatory amino acids in the etiology of epilepsy.
Significant decreases in the area of vacuolization induced by 
i.c.v. KA were observed in the CA3 region of the hippocampus of U- 
50488H-treated mice when quantitated by image analysis. The decreased 
area of vacuolization in the lesioned side of the hippocampus indicates 
that U-50488H previously administered to mice receiving KA protects the 
pyramidal cells of the CA3 region from excitotoxic lesions.
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a ^ C a l c i v u n ,  Amersham, Amersham Corporation, Arlington Heights, 
Illinois, 60005.
b Calcium chloride, Mallinckrodt Incorporated, Science Products 
Division, St. Louis, Missouri, 63134.
c Charles River Breeding Laboratories, Inc., Portage, Michigan, 49001.
d Glass-teflon homogenizer, Kontes Glass Company, Vineland, New 
Jersey.
e Sorvall RC5C Model centrifuge, Sorval Instruments,Bioresearch 
Systems, Sorvall Products, Wilmington, Delaware, 19898.
f Ficoll 400, Pharmacia Fine Chemicals, Division of Pharmacia
Inc., Piscataway, N.J. 08854.
g Beckman Model L2-65 Ultracentrifuge, Beckman Instruments, Inc., 
Bioanalytical Systems Group, Arlington Heights, Illinois, 60004.
h Sorvall Swinging Rotor SW28, Beckman Instruments, Inc.,
Bioanalytical Systems Group, Arlington Heights, Illinois, 60004.
i Bio-Rad Protein Assay Dye Reagent Concentrate, Bio-Rad 
Laboratories, Richmond, Calif. 94804.
j Spectronic 21, Bausch and Lomb, Analytical Systems Division, 
Rochester, New York, 14625.
k Whatman GF/A filters, Whatman International Ltd., Maidstone, 
England.
1 ACS* Aqueous Counting Scintillant,Amersham Corporation, Arlington 
Heights, Illinois, 60005.
ra Phillips 201 Electron Microscope, Phillips Electronic 
Instruments Inc., Mahwah, N.J. 07430.
n Dupont-Sorvall MT 5000 Ultramicrotome, Sorvall Instruments, 
Bioresearch Systems, Sorvall Products, Wilmington, Delaware,
19898.
o Polybed 812, Polysciences, Inc., Warrington, PA,
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p Liquid Scintillation System, Beckman, Scientific Instruments 
Division,
q Whatman GF/B filters, Whatman International Ltd., Maidstone,
England.
r (^H)KA, Amersham, Amersham Corporation, Arlington Heights, Illinois, 
60005.
s Kainic Acid, Sigma Chemical Company, St, Louis, Missouri,
63178.
t 2-(^H)-Deoxy-D-Glucose, E.I. du Pont de Nemours & Co.,
(Inc.), NEN Research Products, Boston, MA 02118.
u Protosol, Du Pont, NEN Research Products, Boston, Massachussetts,
02118.
v Teflon Liners, Du Pont, NEN Research Products, Boston,
Massachussetts, 02118.
w U-50488H, The Upjohn Company, Kalamazoo, Michigan, 49001. 
x Methoxyflurane, Metofane, Pitmann-Moore, Inc., Washington 
Crossing, N.J. 08560.
y Microtome, Leitz 1512, Leitz Leica Wild Heerbrugg, W. Nuhsbaura, Inc. 
Me Henry, Illinois.
z Image analizer, Joyce-Loebl Magiscan 2A, Nikon Inc., Instrument 
Group. 623 Steward Ave, Garden City, NY, 11530.
aa Brinkman Homogenizer, Brinkman Instruments, Westbury, NY, 11590. 
ab Rodent Laboratory Chow #5001. Purina Mills, Inc.
ac Veralba (Proveratrines A and B) Pitman-Moore, Division of the Dow 
Chemical Company, Indianapolis, In.
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APPENDIX 1 - Assay Buffers
A. 0.32 M sucrose 5 mM HEPES buffer
Sucrose
HEPES (Na salt) 
EGTA
pH - 7.4 
Gram/Liter 
109.54 
1.30 
0.19
B. Density gradient solutions
1. Ficoll 4%
Grams/Liter 
Ficoll 40.0
then add 0.32 M sucrose to q.s, 1 liter
2. Ficoll 11%
Grams/Liter 
Ficoll 110.0
then add 0.32 M sucrose to q.s. 1 liter
APPENDIX I continued
G, Incubation medium
1. 5.6 mM KC1 20 mM TRIS buffer
Concentration 
NaCl 136.0 mM
KC1 5.6 mM
MgCl2 1.3 mM
TRIS/HC1 20.0 mM
Glucose 11.0 mM
LaCl3 0.5 mM
2. 74.4 mM KCl 20 mM TRIS buffer
Concentration
NaCl 67.2 mM
KCl 74.4 mM
MgCl2 1.3 mM
TRIS/HC1 20.0 mM
Glucose 11.0 mM
pH - 7.4 
Gram/Liter 
7.95 
0.42 
0.26 
2.42 
1.98 
0.19
pH - 7.4 
Gram/Liter
3.93
5.55
0.26
2.42
1.98
APPENDIX 1 continued
3. 40.0 mM KCl 20 mM TRIS buffer pH - 7.4
Concentration Gram/Liter
NaCl 67.2 mM 3.93
KCl 74.4 mM 5.55
MgCl2 1.3 mM 0.26
TRIS/HC1 20.0 mM 2.42
Glucose 11.0 mM 1.98
LaCl3 0.5 mM 0.19
APPENDIX
1.
2 Incubation buffers
50.0 mM TRIS Buffer
TRIS/Acetic Acid
50.0 mM TRIS/ HCI buffer
TRIS/HC1
pH - 7.1 
Concentration Gram/Liter
50.0 mM 6.06
pH - 7.1 
Concentration Gram/Liter
50.0 mM 6.06
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APPENDIX 3 - 2-(3H)-DG Solution
A. (3H)DG solution
ml
(3H)DG stock 0.5
saline 9.5
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APPENDIX 4 - Mouse Diet
Contents of mouse maintenance diet (*)
Crude protein not less than 23.0%
Crude fat not less than 4.5%
Crude fiber not more than 6.0%
Ash not more than 8.0%
Added minerals not, more than 2.5%
(*) Rodent Laboratory Chow #5001. Purina Mills, Inc.
APPENDIX 5 - Fixative
B. Karnovsky's fixative
Concentration
Paraformaldehyde 20.0 gm
Glutaraldehyde 50% 50.0 ml
Na Cacodylate 0.2 M 500.0 ml
NaOH 1.0 N dropwise until clear solution
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